INTRODUCTION {#s1}
============

This analysis describes a specific one-time, short-duration, chemical airborne release attack scenario at a major U.S. airport as a mechanism to demonstrate key considerations and decision criteria that can facilitate post-attack and post-decontamination consequence management activities. This work reflects information and lessons learned as part of an ongoing U.S. Department of Homeland Security (DHS) domestic preparedness activity, the Chemical Restoration Operational Technology Demonstration Project. A primary objective of this analysis is to provide and document information for chemical warfare agents (CWAs) and toxic industrial compounds (TICs) appropriate and useful to airport facility remediation should such an incident occur.

This work is presented in two parts: Part I ("Key assessment considerations") ([@R135], *this issue)* characterized the airborne release chemical attack scenario at a major U.S. airport that serves as the basis of the evaluation. Scenario assumptions were described, chemicals and populations of concern were characterized, various post-event phases and timelines were summarized, a conceptual site model (CSM) to characterize potential health risks of concern was derived, and precedents and resources were evaluated. The current analysis, which represents Part II ("Decision criteria for multipathway exposure routes"), provides first-time, open-literature documentation of multi-pathway and health-based pre-planning remediation exposure guidelines for CWA and TICs, as well as degradation products, for application in anticipation of a chemical terrorist attack.

BACKGROUND {#s2}
==========

Detailed project background was provided in Part I of this analysis ([@R135], *this issue)* and is only briefly summarized here. The DHS, and specifically the DHS Chemical and Biological Countermeasures Program, has been given responsibility to improve domestic preparedness for potential chemical terrorist release incidents at key U.S. transportation nodes. Focus of this Project has been on the Consequence Management phase *(e.g.*, restoration and recovery) of the response; specifically, effort is directed to pre-plan the recovery process, select "best available" methods and technologies for each recovery activity, and address both data and technology gaps critical to the recovery process. It is recognized that minimizing potential health and economic impacts from chemical attacks is an effective countermeasure to chemical terrorism.

As part of a multi-year research program involving several national laboratories as well as subject matter experts from various state and Federal agencies, the current analysis presents and documents human health-based exposure guidelines for use as an aid to site-specific pre-planning and preparedness for a chemical terrorist incident. This subject area has been under investigation and development during the current work, in which project participants partnered with the Los Angeles International Airport (LAX; Los Angeles, CA) to generate a national case study. While the following exposure guidelines analysis is necessarily site-specific for a single terminal at LAX, many factors common to any restoration operation have been evaluated; results are thus also applicable to other transportation nodes considered vulnerable to chemical terrorist attack.

Airport scenario compounds evaluated include the chemical warfare agent (CWA) nerve agents tabun (GA), sarin (GB), soman (GD), cyclosarin (GF), and VX as well as the vesicant agent sulfur mustard (HD); and the toxic industrial compounds (TICs) phosgene (CG), hydrogen cyanide (AC), and cyanogen chloride (CK). Exposure pathways analyzed include a variety of routes associated with airborne vapors (inhalation and direct ocular vapor, percutaneous vapor) and potential surface residues (surface contact with skin, hand-to-eye transfers, hand-to-mouth ingestion, resuspension inhalation). Populations considered include specifically trained decontamination personnel, transit passengers, and various airport personnel including restoration and recovery personnel performing refurbishment tasks, vendors, gate agents, baggage handlers, and others. Population characteristics, elements of the consequence management analysis, and specific properties for chemicals of concern and their degradation products are detailed in [@R93], *this issue).*

An overall project objective has been to leverage existing resources and guidance. As a consequence, emphasis has been placed on exposure guidelines consistent with parameters of the site-specific and one-time release scenario for which this project is designed. In addition, programmatic focus is maintained on guidelines that already exist, are published and accessible to the public, have undergone credible peer and public review, are health-based and protective, are compound-specific, and have demonstrated utility in use and practice. Airport stakeholders have made it clear that, if a chemical terrorist incident should occur tomorrow, it is important to have an available set of appropriate and reasonable clearance goals from which to begin. It is understood and acknowledged that each release event will involve site- and incident-specific parameters requiring in-context evaluation regarding guideline applicability.

This article does not address public health responses *(i.e.*, medical treatment) or risk management elements.

CURRENT EXPOSURE AND EQUIPMENT GUIDELINES FOR DECONTAMINATION AND EMERGENCY RESPONSE PERSONNEL {#s3}
==============================================================================================

Personal protective equipment and clothing (PPE) selection requirements and related information for emergency response and decontamination personnel (the latter entering the facility to collect characterization or clearance samples, install decontamination equipment, and perform related tasks) are summarized by the National Institute for Occupational Safety and Health (NIOSH) ([@R81]; see: [www.cdc.gov/NIOSH/ershdb/](http://www.cdc.gov/NIOSH/ershdb/) for links to Emergency Response Cards for individual compounds of concern and compound categories). This information is provided as the NIOSH Emergency Response Safety and Health Database (ERSHDB; [www.cdc.gov/NIOSH/ershdb/about.html](http://www.cdc.gov/NIOSH/ershdb/about.html)). Categories of PPE protection *(e.g.*, Level A-D, with A \[Red Zone\] providing the greatest level of protection and D \[Green Zone\] providing the least) are defined on the basis of whether or not identity of the hazardous material is known, as well as atmospheric concentrations relative to exposure limits such as Acute Exposure Guideline Level (AEGL) concentrations. As the NIOSH guidelines are subject to change, the user is advised to confirm the PPE and exposure guideline values posted on the NIOSH sites provided above before field application.

The DHS has also adopted science and technology standards developed by NIOSH or the National Fire Protection Association (NFPA) for personal protective gear for first responders ([@R39]. These chemical response standards specify technical requirements for respirators and clothing.

In addition, the *NIOSH Pocket Guide to Chemical Hazards* and NIOSH emergency response cards ([@R77; @R78]; [@R79; @R80]; [www.cdc.gov/niosh/npg/](http://www.cdc.gov/niosh/npg/)) provide respirator and skin protection recommendations for hydrogen cyanide, cyanogen chloride, and phosgene developed either by NIOSH alone or collaboratively with the Occupational Safety and Health Administration (OSHA). More specific recommendations for nonrespiratory chemical protective clothing (boots, gloves, and suits) are available via a link from the NIOSH website ([@R63]; [www.cdc.gov/niosh/ncpc/ncpcl.html](http://www.cdc.gov/niosh/ncpc/ncpcl.html)). Whereas the *NIOSH Pocket Guide* recommendations have been developed for application to industrial workplaces where personnel can be routinely exposed during manufacture and processing and related industrial activities, many consider these occupational values to be important when considering exposure guidance for decontamination personnel potentially exposed to hydrogen cyanide, cyanogen chloride, or phosgene in the course of their specialized duties. The immediately dangerous to life and health (IDLH) concentrations are particularly relevant.

PERCUTANEOUS VAPOR EXPOSURE TO CWAs {#s4}
===================================

In the event of damage or breach to skin-protective clothing, toxicologically significant vapor contact exposure to skin could be possible in high-vapor concentration situations potentially encountered during emergency response and decontamination activities associated with a CWA attack. Percutaneous vapor concentrations necessary to produce adverse effects similar to those induced following inhalation or ocular vapor exposure to these same compounds are often greater by several orders of magnitude due to skin barrier effects ([@R86]). The U.S. Army Office of the Surgeon General (OTSG) has established emergency military guidelines for percutaneous vapor exposure to allow safe exit from a CWA atmosphere in the event of damage or breach to skin-protective clothing worn by specialized personnel with CWA expertise and under military management, such as personnel employed in military munition demilitarization facilities ([@R29; @R30]) ([Table 1](#T1){ref-type="table"}). It is noted that application of the guidelines shown in [Table 1](#T1){ref-type="table"} assumes that respiratory protection is in place and fully functional throughout CWA exposures and that individuals are under monitoring surveillance.

###### 

Percutaneous vapor exposure guidelines for (military) CWA personnel escape from selected CWA and TIC atmospheres, assuming respiratory protection.[^a^](#T1FN1){ref-type="table-fn"}

  CWA or TIC                       Example CWA personnel escape guidelines (mg/m^3^) for 30-minute percutaneous exposure (with respiratory protection only, or a breach in skin-protective clothing)
  -------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Tabun (GA)                       11.1[^a^](#T1FN1){ref-type="table-fn"}[^b^](#T1FN2){ref-type="table-fn"}
  Sarin (GB)                       6.0[^a^](#T1FN1){ref-type="table-fn"}
  Soman (GD) and Cyclosarin (GF)   1.5[^a^](#T1FN1){ref-type="table-fn"}[^b^](#T1FN2){ref-type="table-fn"}
  VX                               0.13[^a^](#T1FN1){ref-type="table-fn"}[^b^](#T1FN2){ref-type="table-fn"}
  Sulfur mustard (H/HD)            0.1[^a^](#T1FN1){ref-type="table-fn"}[^b^](#T1FN2){ref-type="table-fn"}
  Hydrogen cyanide (AC)            Not determined by NIOSH[^c^](#T1FN3){ref-type="table-fn"}
  Cyanogen chloride (CK)           Not determined by NIOSH[^c^](#T1FN3){ref-type="table-fn"}
  Phosgene (CG)                    Not determined by NIOSH[^c^](#T1FN3){ref-type="table-fn"}

^a^[@R29]; [@R131].

^b^Military guideline established by the Army Office of the Surgeon General (see footnote a). Percutaneous vapor exposure would be a route of concern if personnel wear respiratory protection but experience a rip or tear in the protective suit, or if personnel are in mask-only protective ensemble. Agent vapor concentrations of concern for skin-only exposure are greater than those for vapor exposure to personnel with no respiratory protection (where fast-acting inhalation and ocular exposure would occur).

^c^[@R76].

[@R131] observed that dose effects arising from cumulative percutaneous exposure to the listed CWAs are likely to remain constant for exposures of approximately 30 min to 2 h. Thus, 30 min was selected as a reasonable duration for specialized personnel with CWA expertise to undergo percutaneous exposure to the concentrations provided in [Table 1](#T1){ref-type="table"}. Furthermore, 30 min is considered sufficient to allow specialized personnel with fully functional respiratory protection to perform multiple data collection cycles and to then safely exit from a CWA atmosphere.

Under appropriate PPE and administrative controls, the available U.S. Army Office of the Surgeon General guidelines for percutaneous vapor exposure ([Table 1](#T1){ref-type="table"}) could be reasonably considered for application in safeguarding civilian decontamination personnel.

The relative toxicity of percutaneous vapor exposure versus direct inhalation/ocular exposure has not been clearly established for the TIC compounds of concern. Neither cyanogen chloride nor phosgene vapors are known to be dermally absorbed. Existing reports of toxicity for the scenario TICs focus exclusively on inhalation toxicity since any percutaneous vapor absorption is widely considered to be a less significant source of exposure than vapor inhalation. Although percutaneous absorption of HCN (agent AC) vapor occurs (the NIOSH short-term exposure limit \[STEL\] for HCN has a skin notation; [@R76; @R77]), the relative importance of skin exposure for HCN is not well characterized. Anecdotal human data ([@R10] for HCN and experimental animal data reviewed by the American Industrial Hygiene Association ([@R6] indicate that markedly higher (greater than 40-fold) concentrations may be required to induce lethality when HCN vapor exposure occurs percutaneously rather than by inhalation. NIOSH has not developed percutaneous vapor exposure guidelines for cyanogen chloride or phosgene.

INHALATION/OCULAR EXPOSURE GOALS SUITABLE FOR GENERAL PUBLIC UNDER LAX AIRPORT SCENARIO {#s5}
=======================================================================================

As previously documented, the air exposure pathway is a key focus for developing clearance and re-occupancy goals for the scenario compounds; in addition, the release scenario hypothesized in this evaluation assumes that a CWA or TIC source is removed, neutralized or otherwise terminated during the first-response phase and that the absence of further agent release is frequently verified and validated under standard protocols for monitoring air and personnel at the site. Because the average passenger dwell time in the terminal is much less than 8 h ([@R20], the short-term exposure durations assumed here reflect actual and measured dwell times by airline passengers in modern, commercial airport terminals.

For similar reasons, any assumptions of continuous exposure to the chemicals of concern are rejected as incompatible with expected jobsite conditions for various airport personnel performing tasks associated with repair, maintenance, replacement or servicing of airport components and facilities; as well as airport employees *(e.g.*, gate agents, baggage handlers) and vendors. In other words, this description encompasses all airport personnel performing tasks other than decontamination of CWAs or TICs. Remediation protocols ([@R135], *this issue)* require that all of these tasks and services be performed only after obtaining confirmation that (1) the agent source is removed and/or neutralized, (2) all forensic assessment is completed, (3) any decontamination processes are completed and verified, and (4) clearance sampling has characterized atmospheres. The airport response protocol recommends that any subsequent detection of compounds of concern at clearance concentrations would result in the prompt exclusion of personnel until additional remediation occurs. As a result of the protection afforded by source removal, decontamination, and clearance sampling before initiating restoration and recovery tasks, protective assumptions developed for transit passenger populations are also considered appropriate for all airport personnel performing tasks other than decontamination of CWAs or TIC, and vendors. All of the above populations are considered to be members of the general public.

Of the many options considered, those short-term exposure concentrations developed by the National Research Council Committee on Toxicology (NRC/COT) in collaboration with the U.S. Environmental Protection Agency\'s (USEPA\'s) National Advisory Committee for Acute Exposure Guideline Levels (AEGLs) for Hazardous Substances offer several advantages. AEGLs are available for several tiers (1, 2, 3) of gradually increasing toxic effects and multiple exposure durations, have undergone rigorous peer review (including publication in the *Federal Register* for public comment), and have employed a modern and systematic approach to data analysis in a manner transparent to the public and other stakeholders ([@R84; @R85; @R86]). The established review process ensures appropriate scientific credibility and peer review. In addition, AEGL values are available for the specific compounds of interest and are currently being implemented by local, state, and Federal agencies in preparation for accidental or intentional releases \[[@R93], *this issue)* discussion of "Precedents and Sources"). Use of these values allows for identification of an initial and credible starting point and, depending on the incident- and site-specific parameters, can be adjusted accordingly.

Because of their recognized scientific credibility and expanding uses in domestic preparedness planning by affected communities as well as Federal and state authorities, this analysis considers the AEGL concentrations as protective, appropriate and useful for making site-access re-entry determinations for the traveling public, airport personnel, and vendors. This analysis further considers application of the mildest effect tier (AEGL-1) ([@R84]) to be appropriate, and application of the 8-h AEGL-1 concentrations (the lowest values) as reasonable criteria for all transit passenger stay times ≤8 h as well as for airport personnel and vendors. Selecting the minimal exposure concentrations developed for assumed 8-h exposure durations is a highly protective assumption for LAX transit passengers given the one-time only release scenario and the fact that most passengers spend ≤4 h in the most heavily used LAX terminals ([@R20]). It is acknowledged that use of any given dwell ("stay") time assumption may be airport-specific; nevertheless, the 8-h continuous-exposure durations evaluated above are considered protective for post-decontamination applications.

The values presented in [Table 2](#T2){ref-type="table"} provide compound-specific and protective air concentrations for clearance screening decision-making. The "reasonable maximum clearance goals" compound-specific concentrations are for an assumed, continuous-exposure duration of 8 h derived under the AEGL derivation protocol of [@R84]. Therefore, this concentration is considered protective not only for exposure durations of 8 h, but also for shorter-term exposure durations of \< 8 h. This approach is precautionary given data documenting that the passenger transit time at LAX is much less than 8 h ([@R20]). Clearance goal selection of a vapor concentration for the unlikely continuous CWA or TIC exposure duration of 8 h is thus considered highly protective. To address those rare situations where public dwell times may be \>8 h but \<24 h, alternative clearance goals are also provided in [Table 2](#T2){ref-type="table"}. These clearance goals are derived in the current analysis from standard time-extrapolation protocols ([@R84]), and provide additional flexibility to decision-makers. The range provided in [Table 2](#T2){ref-type="table"} represents both reasonable maximum and alternative re-entry screening guidelines.

Limitations in toxicity data for cyanogen chloride ([@R24]) and phosgene have restricted development of short-term exposure concentration guidelines, and result in absence of some or all final AEGL or Emergency Response Planning Guideline (ERPG) values for these two compounds. Accordingly, this evaluation developed protective estimates for phosgene and cyanogen chloride specifically designed for application to the LAX scenario. Because the estimates are unique to the present analysis, a comprehensive explanation of the derivation is provided below and in footnotes of [Table 2](#T2){ref-type="table"}. Comparable detailed guideline explanations are not provided for the remaining CWAs and TICs, given that this material has already been widely published and is incorporated by reference in this analysis *(e.g.*, [@R85; @R86]; [@R132; @R133]; [@R12]; [@R143]; others).

###### 

Recommended airborne (inhalation, ocular) pre-planning clearance goals for transit passengers as well as various airport employees and personnel for selected CWAs and TICs.[^a^](#T2FN1){ref-type="table-fn"}

                                   Reasonable maximum clearance goals (mg/m^3^)    Alternative clearance goals (mg/m^3^)
  -------------------------------- ----------------------------------------------- -----------------------------------------------
  Tabun (GA)                       \< 0.0010[^c^](#T2FN3){ref-type="table-fn"}     \< 0.0003[^e^](#T2FN5){ref-type="table-fn"}
  Sarin (GB)                       \< 0.0010[^c^](#T2FN3){ref-type="table-fn"}     \< 0.0003[^e^](#T2FN5){ref-type="table-fn"}
  Soman (GD) and Cyclosarin (GF)   \< 0.00050[^c^](#T2FN3){ref-type="table-fn"}    \< 0.0002[^e^](#T2FN5){ref-type="table-fn"}
  VX                               \< 0.000071[^c^](#T2FN3){ref-type="table-fn"}   \< 0.000024[^e^](#T2FN5){ref-type="table-fn"}
  Sulfur mustard (H/HD)            \< 0.008[^c^](#T2FN3){ref-type="table-fn"}      \< 0.003[^e^](#T2FN5){ref-type="table-fn"}
  Hydrogen cyanide (AC)            \< 1.1[^d^](#T2FN4){ref-type="table-fn"}        \< 0.37[^e^](#T2FN5){ref-type="table-fn"}
  Cyanogen chloride (CK)           \< 0.25[^f^](#T2FN6){ref-type="table-fn"}       \< 0.08[^f^](#T2FN6){ref-type="table-fn"}
  Phosgene (CG)                    \< 0.08[^g^](#T2FN7){ref-type="table-fn"}       \< 0.03[^g^](#T2FN7){ref-type="table-fn"}

^a^Chemical formulae: tabun, C~5~H~11~N~2~O~2~P (NATO code GA); sarin, C~4~H~10~FO~2~P (NATO code GB); soman, C~7~H~16~FO~2~P (NATO code GD); cyclosarin, C~7~H~14~FO~2~P (NATO code GF); VX, C~11~H~26~NO~2~PS (NATO code VX); sulfur mustard, C~4~H~8~Cl~2~S (NATO code HD); hydrogen cyanide, HCN (NATO code AC); cyanogen chloride, CNCl (NATO code CK); phosgene, COCl~2~ (NATO code CG).

^b^May also be used as appropriately protective and health-based vapor screening criteria for releasing items, equipment, and facilities that have not been exposed to liquid or heavy aerosol forms of the chemical of concern; these screening criteria would also be useful for evaluating non-porous items and surfaces that have undergone decontamination. If these vapor screening criteria are attained, such decontaminated items would not be expected to pose a vapor exposure hazard ([@R32], Table C-5).

^c^[@R86].

^d^[@R85].

^e^Proposed \>8 but ≤24-h protective estimates presented for use in this analysis are derived by straight-line extrapolation from the 8-h AEGL-1 values and follow standard protocols ([@R84]).

^f^In the absence of a previously derived CK exposure guideline comparable to AEGL-1, these estimates were calculated for use in the current assessment (see text for details of derivation. and [@R140]). 8-h estimate is derived from experimental data with straight-line extrapolation to 24 h. This derivation is considered a reasonable approach given the absence of published AEGL-1 values for cyanogen chloride.

^g^In the absence of a previously derived phosgene (agent CG) exposure guideline comparable to the AEGL-1, these estimates were calculated for use in the current assessment (see text for details of derivation). 8-h estimate is derived as 50% of 8-h AEGL-2 for phosgene ([@R85]), with straight-line extrapolation to 24 h. This derivation is considered a reasonable approach given the absence of published AEGL-1 values for phosgene.

Related Considerations {#s6}
----------------------

Inhalation minimal risk levels (MRLs) were also considered in this analysis, but are only available for sulfur mustard agent HD (the MRL for an "acute-duration" exposure of ≤14 days is 0.0007 mg HD/m^3^; MRL for "intermediate-duration" exposure of 15 to 364 days is 0.00002 mg/m^3^) ([@R8]). The acute MRL for agent HD differs from the minimal re-entry screening guideline for HD in [Table 2](#T2){ref-type="table"} by an approximate factor of 4. Given that the Agency for Toxic Substances and Disease Registry (ATSDR) assumptions of multiple-day and continuous exposure duration are not supported by the release and decontamination scenario governing development of this airport remediation analysis, the extended-release inhalation MRLs for HD are not further considered as clearance guidance for the airport scenario.

The Standing Operating Procedure for an ongoing effort by USEPA/National Homeland Security Research Center to develop emergency reference levels has been recently published ([@R144]). These levels (Provisional Advisory Levels; PALs) are being derived for assumed continuous 24-h, 30-d, 90-d, and 2-yr exposure durations for both inhalation and oral exposure routes and 3 tiers of effect, with tier 1 being least severe and tier 3 being most severe. As provisional values, PALs are considered "temporary values that will neither be promulgated, nor be formally issued as regulatory guidance" ([@R4]). Rather their intent is to "assist in emergency planning and decision-making," and for use at the discretion of risk managers.

The \>8 h but \<24 h protective vapor concentration estimates for the CWAs and TICs in [Table 2](#T2){ref-type="table"} have been compared with compound-specific PALs ([@R134]; [@R46; @R47]; see also [www.epa.gov/NHSRC/news/news121208.html](http://www.epa.gov/NHSRC/news/news121208.html)). PAL values for phosgene were recently published in [@R47]; PAL values for HCN, the G-series nerve agents, nerve agent VX and sulfur mustard agent HD are within USEPA review at this writing and are not available for examination unless specifically requested ([www.epa.gov/NHSRC/news/news121208.html](http://www.epa.gov/NHSRC/news/news121208.html)).

For the lowest effect level (PAL 1) and 24 h exposure duration to the public, the PAL 1 vapor concentrations for the G-agents are similar to the \>8 h but \< 24 h protective estimates in [Table 2](#T2){ref-type="table"}. The draft nerve agent PAL vapor estimates have undergone extensive review and have been approved as scientifically sound by the PAL Advisory Panel for internal USEPA use, although they have not yet been released for public access or use as of August 2010. Internal analysis during the current evaluation has noted close similarity between compound-specific LAX preplanning clearance goals ([Table 2](#T2){ref-type="table"}) for \>8 h but \<24 h, and both G-agent and nerve agent VX 24-h PAL 1 values for inhalation/ocular exposure. The draft 24-h PAL 1 values for sulfur mustard, phosgene, and hydrogen cyanide differ slightly from the compound-specific LAX remediation guidance protective estimate for \>8 h but \<24 h ([Table 2](#T2){ref-type="table"}). At present (August 2010), no 24-h PAL 1 vapor exposure estimates are available for cyanogen chloride due to sparse data. When PAL values are made broadly available in a manner that facilitates transparent examination by state and local regulatory authorities and members of the general public, they can be more readily provided to decision-makers for further consideration.

Derivation of Airport Inhalation/Ocular Exposure Guidelines {#s7}
-----------------------------------------------------------

### Guideline level basis for chemical warfare agents {#s8}

The [@R84] describes and documents selection protocols for critical effects and studies, AEGL derivation, time scaling, use and selection of uncertainty and modifying factors, and a description of the lengthy and deliberative review process employed. This material is also available in recent papers by [@R62] and [@R132; @R133]. Because exposure-response data are usually not available for each AEGL-specific exposure duration (for any hazardous chemical and not just CWAs; [@R84]), temporal extrapolation is employed in the development of AEGL values for some AEGL-specific time periods. The concentration-exposure time relation for many systemically acting vapors and gases may be described by *C^n^* × *t = k*, where the exponent *n* ranges from 0.8 to 3.5 (C is concentration in mg/m^3^ and t is exposure duration time; [@R107]). Haber\'s rule *(C* × *t = k)* is a special case of this principle, and occurs when *n* = 1; Haber\'s rule has often been used for short-term exposure predictions involving a small set of highly toxic gases ([@R84]). For larger sets, and structurally heterogeneous compounds, the more general relation of *C^n^* × *t = k* applies ([@R107]; [@R84]).

In general, toxicity data from human studies are preferred for AEGL development over those obtained from animal studies ([@R84]). Furthermore, vapor exposure data are preferred over those available from alternate exposure pathways ([@R84]). Human studies evaluated in the AEGL process must meet rigorous ethical criteria for acceptance of human subject data in that (1) subjects should provide informed consent, and (2) there is evidence that human studies were performed under appropriate clinical supervision ([@R84]). Final AEGL values for nerve agents and sulfur mustard are published in [@R86], while final values for phosgene and hydrogen cyanide are published in [@R85]. AEGL values for cyanogen chloride have never been finalized due to scarcity of data.

When available, AEGL-1 values for the 8 h continuous exposure duration (the longest duration considered in the AEGL process, and consequently associated with the smallest AEGL exposure concentration) are incorporated into the LAX remediation guidance as reasonable maximum re-entry screening guidelines for all the reasons outlined earlier. Application of standard time-extrapolation protocols ([@R84]) provides additional flexibility in estimating an alternative re-entry screening guideline for rare instances when potential exposure durations could be \>8 h but \<24 h. A summary of compound-specific derivation follows.

*AEGL-1 derivation for sarin and other nerve agents.* The toxicological database for agent GB is robust and includes sufficient human and animal data for derivation of AEGL-1 and AEGL-2 estimates as well as ample laboratory animal lethality data for directly deriving AEGL-3 values. AEGL-1 values for agent GB were derived from a well-conducted study on adult female Sprague-Dawley (SD) rats subjected to whole-body exposures in a dynamic airflow chamber to a range of GB vapor concentrations (0.01 to 0.48 mg/m^3^) for exposure durations of 10, 60, or 240 min ([@R73; @R74]). The endpoint of interest and point of departure was the well-defined median effective concentration (EC~50~) for reversible and transient miosis in a susceptible gender (female; [@R34; @R35]); this degree of miosis is not considered adverse in humans ([@R86]) and is a direct, local, and transient effect to the ocular iris.

Of the 283 GB-exposed rats, 142 were female and 141 were male. With the inclusion of range-finding experiments and controls, a total of 423 rats was tested in the well-conducted study of [@R73; @R74], which employed highly credible protocols for GB vapor generation and measurement. Analysis of pre- and post-exposure rat pupil diameters allowed determination of EC~50~ values for miosis (defined by Mioduszewski and his colleagues as a post-exposure pupil diameter of 50% or less of the pre-exposure diameter in 50% of the exposed population). Blood samples collected from tail vein and heart at 60 min and 7 d post-exposure indicated no significant change from pre-exposure baseline in monitored blood RBC-ChE (red blood cell cholinesterase), BuChE (butylcholinesterase), or carboxylesterase activity. No other clinical signs were evident throughout the duration of the study. Thus, the potential for systemic absorption was evaluated, and did not occur. These results further document the fact that miosis alone, and in the absence of signs such as cholinesterase or carboxylesterase activity inhibition, is a local effect reflecting an exposure much less than that required to generate a systemic clinical effect. Gender differences (females more susceptible) were statistically significant. The EC~50~ for miosis in female SD rats is thus a well-defined transient, reversible, and nondisabling animal endpoint in a susceptible gender.

An EC~50~ for miosis is widely considered the first measurable change (and first noticeable effect, or FNE) by modern and reproducible techniques in the continuum of response to anticholinesterase compounds, and is comparable to the pupil size reduction observed in human subjects who enter bright sunlight after time spent in a dimly lit room. During the (1995) Tokyo Subway Incident of GB release by domestic terrorists, persons experiencing much greater than 50% reduction in pupil diameter self-rescued and rendered aid to others ([@R132]).

Since miosis in the absence of other clinical signs occurs as a direct and local vapor exposure effect prior to systemic effects such as whole blood acetylcholinsterase (AChE) activity depression, and is the FNE associated with exposure to low-level nerve agent vapor concentrations ([@R34; @R35]), the [@R86] considered this endpoint to be a highly protective point of departure for prevention of systemic effects and estimating acceptable inhalation vapor exposure concentrations. The authors agree with this assessment.

When compared to the human data, [@R86] determined that miosis data derived from the [@R73; @R74] study on rats are a more reliable dataset because of the contemporary and multiple analytical techniques employed for quantifying exposures and measuring miosis, and the experimental protocol incorporating sufficiently large test and control populations. With the additional knowledge that the EC~50~ for miosis exhibited by rats in the study of [@R73; @R74] is transient and reversible, the EC~50~ for miosis in female (susceptible gender) SD rats is well supported as an appropriate and protective point of departure for estimating AEGL-1 values. Further, the [@R86] ascertained that the miotogenic response of mammal eyes to GB vapor exposure is similar across multiple mammal species, including standard laboratory species (rats, rabbits, and guinea pigs; [@R73; @R74]; [@R19]; [@R125; @R126]), nonhuman primates (marmosets; [@R125; @R126; @R127; @R128]), and humans ([@R52]; [@R57]). As a consequence, the interspecies uncertainty factor (UF~A~) for the critical AEGL-1 endpoint of EC~50~ miosis is equal to 1.

To accommodate known variation in human cholinesterase and carboxylesterase activity that may make some individuals susceptible to the effects of cholinesterase inhibitors, such as nerve agents, the intraspecies uncertainty factor (UF~H~) was set to 10. A modifying factor was not considered applicable. Thus, the total uncertainty factor for estimating AEGL-1 values for agent GB is 10 ([@R86]; [@R132]).

In accordance with standard techniques and procedures ([@R84]; [@R107]), the temporal extrapolation used in estimating AEGL values for GB is based in part on a log-log linear regression of female SD rat miosis data following GB vapor exposures ([@R73; @R74]). Regression analysis of the miosis data yields an *n* value of 2.00 ([@R86]). The experimentally derived *n* = 2 from the [@R71; @R72; @R73; @R74] rat miosis dataset has been used as the scaling function for nerve agent AEGL derivations.

AEGL-1 values for other G-agents and agent VX were derived from those of agent GB by a relative potency protocol ([@R86]; [@R70]; [@R132]). This is considered a toxicologically acceptable approach given that all mammalian toxicity end points observed in the nerve agent dataset represent different points on the response continuum for anticholinesterase effects and that the principal mechanism of mammalian toxicity for the G-agents and agent VX is cholinesterase activity inhibition. As a consequence, target organ effects are considered identical, but different in magnitude. Furthermore, NRC/COT determined that there are no uncertainties for these nerve agents regarding toxic endpoints such as reproductive or developmental effects or carcinogenicity.

Recently published experimental data for GB vapor exposure in nonhuman primates, G-agents in swine, and rats exposed to VX further document the highly protective nature of these recommended clearance values ([@R44; @R45]; [@R34]; [@R138; @R139]).

*AEGL-1 derivation for sulfur mustard.* Effects observed at low vapor concentrations of sulfur mustard are minimal, primarily ocular; and include conjunctivitis, photophobia, and ocular irritation; these effects are transient, nondisabling, and reversible upon cessation of exposure. The eye is considered the most sensitive and rapidly responding target tissue to sulfur mustard vapor, and the conjunctival endpoint is a direct and local vapor exposure effect to the ocular tissues. As such, and given that this mild ocular tissue response represents first noticeable effects (FNE), this endpoint is considered by [@R86] as a protective point of departure for estimating acceptable respiratory exposure concentrations and AEGL-1 values. This ocular FNE develops prior to manifestation of any respiratory or further systemic effects resulting from inhalation exposure to sulfur mustard vapor ([@R86]; [@R143].

Available ocular studies include controlled exposures to human volunteers as well as characterizations of war casualties and occupational exposures. Of these, only the controlled laboratory studies are suitable for use in deriving AEGL-1 values. The human-subject studies by [@R97], [@R98], [@R129], [@R49], and [@R7] provide useful information for assessing minimal adverse effect levels, and are described below.

The human subject data of [@R7] characterize ocular effects under hot weather conditions when various parameters (high skin temperature and presence of moisture leading to an elevated sulfur mustard reaction rate) combine to enhance the alkylating action of sulfur mustard vapor to exposed epithelial tissues. The [@R7] dataset thus represents a "worst-case" exposure scenario. Under temperate weather conditions, ocular effects following vapor exposure would occur at higher sulfur mustard vapor concentrations. Thus, derivation of AEGL estimates for sulfur mustard from the [@R7] data provides a protective estimate for exposures that may occur under typical ambient conditions.

[@R7] reported no effects at a sulfur mustard cumulative exposure *Ct* of 12 mg-min/m^3^, whereas 30 mg-min/m^3^ represented the upper range for mild ocular effects of conjunctival swelling and minor discomfort with no functional decrement. Slightly higher cumulative exposures *(e.g., Cts* of 34 to 38.1 mg-min/m^3^) were also without appreciable ocular effects. Thus, the [@R7] human data indicate that the ocular response to 30mg-min/m^3^ is consistent with AEGL-1 effects. Analysis of the exposure-effect values from these human studies further indicates that the lower, 12mg-min/m^3^ value represents a defensible estimate of the no-effects threshold for ocular effects, and is thus a protective point of departure for estimating an AEGL-1 value.

Use of human data results in an interspecies UF = 1; furthermore, the use of human-subject data allows application of an intraspecies UF of 3 for protection of sensitive individuals. The adjustment is considered appropriate for acute exposures to chemicals whose mechanism of action primarily involves surface contact irritation of ocular and/or respiratory tract tissue rather than systemic activity that involves absorption and distribution of the parent chemical or a biotransformation product to a target tissue. [@R7] noted that there was little variability in the ocular responses among individual participants.

Analysis of data characterizing similar ocular effects, as reported by [@R97], [@R98], [@R49], and [@R7], indicate that for exposure periods up to several hours, the concentration-exposure time relation is a near-linear function *(i.e.*, Haber\'s Law where *n* = 1 for *C^n^* × *t = k)* as shown by *n* values of 0.96 and 1.11 for various datasets consistent with AEGL-1 effects. Therefore, an empirically derived, chemical-specific estimate of *n* = 1 was employed, rather than a default value, in the derivation. Derivation of the exponent *(n)* utilized human response data where 75 to 100% of responders showed a mild response that would be consistent with the definition of AEGL-1 effects.

Because human subject data collected under hot-weather conditions (resulting in enhanced toxicity) were employed as the critical effects and points of departure for sulfur mustard AEGL-1 derivation, the resulting AEGL estimates are considered highly protective and incorporate small uncertainty (interspecies UF = 1; intraspecies UF = 3; composite UF = 3) ([@R86]; [@R132]).

*Protective nature of CWA guidelines.* The selection of direct local effects to the eye is a protective approach to critical effect determination, especially when the ocular effects observed occur in the absence of systemic toxicity signs. Additional protection is conferred by the knowledge that these endpoints (EC~50~ for miosis in the case of nerve agents; mild ocular irritation and conjunctivitis in the case of sulfur mustard) are transient and reversible ([@R86]; [@R132]). The NRC does not consider the EC~50~ for miosis as an adverse effect in humans, and NRC notes that the level of ocular irritation expressed at the sulfur mustard critical effect endpoint occurs in the absence of functional decrement ([@R86]). Incorporation of various uncertainty factors inherent to the AEGL process results in an 8-h AEGL-1 concentration that is at least one, and often several, orders of magnitude below those concentrations known to generate miosis (nerve agents) or ocular irritation (sulfur mustard) in humans ([@R132]; and Figures 5, 9, and 13 therein).

When further compared against longer-duration data, these endpoints continue to remain protective. For example, experimental rats exposed to 0.001 mg GB/m^3^ (equivalent to the reasonable maximum clearance goal for 8-h exposure duration as presented in [Table 2](#T2){ref-type="table"}) for 6 h/d, 5 times/wk over 24 consecutive weeks exhibited no miosis, no RBC-ChE activity inhibition; and no signs of neuromuscular, GI, respiratory, or behavioral effects ([@R136]). In the case of sulfur mustard, dogs exposed to a time-weighted average concentration of 0.03 mg HD/m^3^ (with peaks at 0.1 mg HD/m^3^ for 6.5 h/d), 5 d/wk for 8 consecutive weeks exhibited no ocular or any other agent-related effects ([@R65]). The experimental time-weighted concentration of 0.03 mg HD/m^3^ from [@R65] is approximately 4 times greater than the reasonable maximum clearance goal presented in [Table 2](#T2){ref-type="table"} *(e.g.*, 0.008 mg HD/m^3^), and an order of magnitude greater than the alternate clearance goal *(e.g.*, 0.003 mg HD/m^3^) for HD exposure durations \>8 but\< 24 h ([Table 2](#T2){ref-type="table"}).

### Guideline level basis for selected toxic industrial compounds (TICs) {#s9}

Of all TICs evaluated in this assessment, hydrogen cyanide (CAS \# 74-90-8) is the most completely characterized; available values include AEGL 1, 2, and 3 concentrations for all AEGL exposure durations ([@R85]); Emergency Response Planning Guidelines (ERPGs) ([@R6]; Integrated Risk Information System (IRIS) reference concentration (RfC) and reference dose (RfD) estimates ([@R122]; NIOSH and OSHA industrial workplace exposure guidelines ([www.cdc.gov/niosh/npg; www.cdc.gov/niosh/ershdb](http://www.cdc.gov/niosh/npg;www.cdc.gov/niosh/ershdb)), and others. The HCN dataset is rich and robust, and includes well-conducted studies of human and nonhuman primate subjects as well as standard laboratory species ([@R85]; [@R10]. Pre-planning clearance goals for the LAX chemical terrorism release scenario could thus be developed in a manner similar to that for the CW agents; for example, selection of the 8 h AEGL 1 concentration (1.1 mg HCN/m^3^ derived from lowest NOAEL for mild headache in humans; [@R85]) as a reasonable maximum, and estimation of an extrapolated alternative value (0.37 mg HCN/m^3^) for application in uncommon situations when a more lengthy dwell time (\>8 h but \<24 h) is possible ([Table 2](#T2){ref-type="table"} and footnotes d and e).

Available data from which to estimate exposure guidelines for low-concentration exposures to cyanogen chloride and phosgene are less robust than those available for the CW agents. As a consequence, certain reasonable assumptions were required to develop exposure guidelines for these TICs, and are documented below.

As outlined earlier for the CW agents, the airport scenario considers that various airport employees and personnel would be allowed access to, and occupancy of, airport facilities only after decontamination for these volatile TICs is complete and monitoring has characterized workspace atmospheres. Ongoing monitoring will ensure that exposures (if any) to compounds of concern would be extremely limited given that detection of cyanogen chloride, phosgene or hydrogen cyanide would result in the prompt exclusion of such personnel until additional remediation occurs. As a result of the protection afforded by monitoring and the time limits such monitoring imposes on potential exposures, protective estimates developed for transit passenger populations are also considered appropriate for airport employees and personnel.

*Cyanogen chloride.* Cyanogen chloride (CK) is the least characterized of all compounds considered under the airport scenario.

Existing exposure estimates for CK. Literature analysis identified no ERPG-1, AEGL-1, or reference concentration (RfC; USEPA Integrated Risk Information System, IRIS) for CK. The [@R5] does not recommend an ERPG-1 concentration for CK because "serious health effects-including marked irritation-may occur below the odor thresholds" of 0.8 to 1.0 ppm CK (2.01 to 2.51 mg CK/m^3^), and CK odor thresholds are greater than the ERPG-2 concentration of 0.4 ppm (1.0 mg/m^3^). The National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances (NAC) has considered CK and commissioned development of a draft technical support document for estimating AEGL values for this compound ([@R140]). At present, the NAC has declined to propose or finalize AEGL values for CK because of data limitations and minimal documentation characterizing dose response and experimental protocols.

As a result, the present assessment considers the logic and protocols for RfC and AEGL derivation as a way of evaluating information critical to development of protective airborne estimates for the transient traveling public, a principal population of concern.

Data and options for CK. In the absence of suitable CK-specific toxicity data, [@R92] estimated two oral reference doses (RfD~e~) for CK on the basis of cyanide toxicity. One estimate (0.035 mg/kg-d) is based on reproductive toxicity in cyanide (CN^−^)-exposed rats ([@R88], in which both a lowest adverse effect level (LOAEL) and a no observable adverse effect level (NOAEL) were identified. The second RfD estimate (RfD~e~ = 0.026 mg CK/kg-d) from [@R92] was developed from human data reported by the [@R68; @R69]) and based on effects associated with ingestion of CN^−^ found naturally in cassava. [@R92] selected the estimated value of 0.03 mg CK/kg-d as the best RfD estimate. An RfC~e~ of 0.035 mg CK/m^3^ can be derived from this RfD~e~ by adjusting for adult body weight (70 kg), adult inhalation rate (20 m^3^/d), and applying an uncertainty factor of 3 to account for extrapolation between ingestion and inhalation exposure routes. If no adjustment is made for route-to-route extrapolation, the RfC~e~ would be 0.11 mg CK/m^3^.

The [@R123] calculated an RfD for cyanogen chloride of 0.05 mg CK/kg-d based on data from a 1955 chronic dietary study in which rats were fed food fumigated with HCN ([@R55]). A NOAEL was identified for CN^−^ and converted to an equivalent dose of cyanogen chloride. The RfD was calculated by applying uncertainty factors of 10 each for extrapolation between species and for sensitive subpopulations, and a modifying factor of 5 to account for tolerance to CN^−^ that may develop when exposure is via the diet rather than by gavage or ingestion in drinking water. This value can be directly extrapolated to an RfC estimate (0.18 mg CK/m^3^) by assuming that the uncertainty factor for extrapolation between exposure routes is 1, and adjusting for adult body weight (70 kg) and inhalation volume (20 m^3^/d). Alternatively, applying an uncertainty factor of 3 to adjust for route-to-route extrapolation gives an RfC estimate of 0.058 mg CK/m^3^.

Prior to 2008, Region 9 of the USEPA developed an air preliminary remediation goal (PRG) for cyanogen chloride as an exposure guideline for chronic lifetime inhalation exposure. \[PRGs are risk-based concentrations intended to be used as guidelines by risk assessors in initial screening-level evaluations of environmental measurements ([www.epa.gov/cgi-bin/](http://www.epa.gov/cgi-bin/))\]. Region 9 extrapolated directly from the USEPA IRIS oral RfD of 0.05 mg CK/kg-d to an inhalation RfD of 0.05 mg CK/kg-d. By applying several default exposure assumptions ([@R116; @R117]), USEPA Region 9 calculated an ambient air PRG of 0.18 mg CK/m^3^. This value was withdrawn in 2008 when Region 9 recommended the use of Regional Screening Levels (RSLs) to replace region-specific PRGs. No new chronic ambient air concentration for CK is proposed because current derivation protocols do not support extrapolation from oral RfDs. Estimated RfC values for cyanogen chloride are shown in [Table 3](#T3){ref-type="table"}.

[@R140] examined human case reports of CK exposures, epidemiological studies conducted at CK-manufacturing facilities and experimental animal data for the NAC. The concentration of 1 ppm (2.51 mg/m^3^) is generally accepted as the lowest irritant concentration for a 10-min exposure ([@R51]), but this concentration has also been reported to result in copious tearing of the eyes in some persons ([@R95]; [@R56]). Human exposure concentrations of 2 and 20 ppm (5.02 and 50.2 mg/m^3^) are reported to be intolerable after 10- and 1-min exposures, respectively ([@R51]; [@R43]). Increased exposure duration to lower concentrations in humans (no duration or concentration specified) can result in inflammation of the conjunctiva and hoarseness ([@R43]). A minimum detectable odor of 0.6 ppm (1.5 mg/m^3^) has been reported ([@R56]). For both lethal and nonlethal effects of cyanogen chloride, humans appear to be the most sensitive species. Although irritation and pulmonary edema have been observed in animal studies, these signs occur at concentrations greater than the approximate human irritation threshold of 1 ppm (2.51 mg/m^3^). Nonlethal studies of CK-exposed experimental animals are limited. Dogs recovered from exposure to either 20 ppm (50 mg/m^3^) for 20 min or 120 ppm (302 mg/m^3^) for 8 min, but not without severe injury ([@R51]; [@R43]). These concentrations are more than one order of magnitude greater than the concentrations known to elicit signs and symptoms in humans.

###### 

Summary of estimated RfC values for CK.

  Derived from information in these sources          Estimated RfC (mg/m^3^)                  Uncertainty factor for route-to-route extrapolation
  -------------------------------------------------- ---------------------------------------- -----------------------------------------------------
  [@R92]                                             0.11                                     1
                                                     0.035                                    3
  USEPA IRIS                                         0.18                                     1
                                                     0.058                                    3
  USEPA Region 9[^a^](#T3FN1){ref-type="table-fn"}   0.18[^a^](#T3FN1){ref-type="table-fn"}   1[^a^](#T3FN1){ref-type="table-fn"}

^a^Withdrawn in 2008.

[@R140] developed a draft technical support document that estimated an AEGL-1 for CK on the basis of the reported minimum irritating concentration in humans from [@R51] *\[i.e.*, 1 ppm (2.51 mg/m^3^)\]. Although a NOAEL is not identified in the available human data, this minimum irritation concentration of 1 ppm is not reported to be intolerable or debilitating. Application of an uncertainty factor of 3 (for intraspecies variability) was considered appropriate because the mechanism of action (and resulting physiological response) for an irritant vapor is not expected to vary greatly among individuals in the population. The NAC considered in 1997 that irritation described for CK is not likely to depend on exposure duration for durations between 10 min and 8 h. As a consequence, the NAC decided that it was not necessary to time-extrapolate between the estimated 10-min AEGL-1 \[0.33 ppm (0.83 mg/m^3^)\] and the estimated 8-h AEGL-1 \[also 0.33 ppm (0.83 mg/m^3^)\] ([@R140]).

Given the incompleteness of toxicity data for CK, the present analysis concludes that it is appropriate to apply an additional uncertainty factor of 3 to the minimum irritant concentration of 1 ppm in humans ([@R51]). Application of the resulting composite uncertainty factor of 10 (3 for intraspecies variability and 3 for database incompleteness) yields a concentration of 0.1 ppm (0.25 mg/m^3^) as a protective estimate that is applicable to exposure durations less than 8 h. This value is 3-fold lower than the draft AEGL-1, and is also less than the TLV© of 0.75 mg/m^3^ ([@R2; @R3]). Under maximal continuous exposure durations assumed in the current analysis (greater than 8 h but less than 24 h), a protective assumption of possible cumulative irritant effects is made. Thus, straight-line extrapolation from 8 h to 24 h provides a protective estimate of 0.03 ppm (0.08 mg/m^3^).

Developing protective CK estimates for airport scenario. In the absence of contemporary experimental data, an ERPG-1 or a finalized AEGL-1, this analysis recommends the following health-protective estimates as pre-planning clearance goals for remediation ([Table 2](#T2){ref-type="table"}) under the LAX airport scenario parameters governing this remediation assessment:

-   Exposure durations of \<8 h: 0.1 ppm CK (0.25 mg CK/m^3^).

-   Exposure durations of \>8 h but \<24 h: 0.03 ppm CK (0.08 mg CK/m^3^).

*Phosgene.* Low-level exposure data for phosgene are sparse. The focus of this evaluation is to identify those data adequate to support estimating a protective exposure concentration of phosgene, as an AEGL-1 has never been developed for this compound ([@R85]).

Existing exposure estimates for phosgene. Examination of the AEGL database, as well as contact with staff and technical contractors managing the database, found general concurrence that toxicity data on phosgene are inadequate to meet standard protocols ([@R84]) for deriving an AEGL-1 for any exposure duration. For similar reasons, no ERPG-1 has been developed for phosgene by the AIHA. Available reports and data considered for remediation guidance development include [@R26], [@R27; @R28], [@R41], [@R58], [@R60], [@R85], [@R109], and [@R103].

Data and options for phosgene. From an examination of data from [@R26], [@R27; @R28], [@R41], and their evaluation by [@R85], the present analysis draws the following conclusions. At the low exposures tested (0.125 to 1 ppm, or 0.5 to 4 mg/m^3^),

-   there is no indication that effects such as decrease in lung ATP (adenosine triphosphate) concentrations as well as increased bronchiolar alveolar lavage fluid protein in the laboratory rat are clinically significant.

-   there is no indication that the experimentally observed low-level effects noted above are likely to progress to a clinically significant level.

In other experiments, [@R103] and [@R60] used identical exposure protocols in which rats were exposed to 0.1 to 1 ppm (0.4 to 4 mg/m^3^) phosgene 6 h/d for 4 or 12 wk, followed by a 4-wk recovery period. In [@R103], the statistically significant effects of 0.1 ppm (0.4 mg/m^3^) phosgene exposure included (1) Impaired pulmonary clearance of bacteria (animals were challenged with a supra-physiological dose of airborne bacteria after subchronic exposure to phosgene), (2) increased polymorphonuclear leukocytes in bronchoalveolar lavage (BAL) fluid, and (3) decreased number of natural killer cells in BAL fluid.

In [@R60], the statistically significant effects of 0.1 ppm (0.4 mg/m^3^) phosgene exposure included increased lung-to-body-weight ratio, increased lung displacement volume, thickening of terminal bronchioles accompanied by an increased number of inflammatory cells, and increased level of pulmonary hydroxyproline. Collagen staining of the lungs also increased with phosgene exposure, but was not evaluated for statistical significance.

The USEPA ([@R124] utilized data from [@R60] as the principal study for deriving a reference concentration for phosgene. That analysis concluded that collagen staining and elevated pulmonary hydroxyproline levels documented by [@R60] represented pathological changes indicative of fibrosis. Although acknowledging that the reversibility of these effects is not actually known, the USEPA assumed that the changes did, in fact, reflect irreversible lung fibrosis, identified a NOAEL of 0.1 ppm (0. 4 mg/m^3^), and derived an RfC of 3 × 10^−4^ mg/m^3^.

With the exception of the [@R60] data used for RfC derivation, the documented effects of low-level phosgene exposure appear to be reversible and represent indicators (biomarkers) of exposure only. They are not indicative of a functionally or clinically significant effect.

One issue raised in the reviewed papers is whether concentration (*C)* alone, or *C* and time *(Ct)*, are key determinants of observed effects for phosgene. Examination of this issue by the NCR/COT (Subcommittee on AEGLs) determined that both *C* and *t* are important in characterizing the toxicity of phosgene, and that the data do not allow discrimination between *C* and *t* as a key determinant. As a consequence, *n* = 1 for the *C^n^ ×* *t = k* relation, within limits for exposure duration ([@R50]; [@R107]; [@R84]). The current analysis has found no data that would support a value of *n* ≠ 1. [@R85] consider the use of *n* = 1 to be valid for time extrapolation to 8 h. It is noteworthy that Haber\'s Law (*C ×* *t = k;* for *n* = 1) was derived from phosgene data ([@R50]).

Developing protective phosgene estimates for airport scenario. Comparison with human and animal data in the AEGL category plots for phosgene illustrates the protective nature of phosgene AEGL derivations ([@R85]). Data points associated with the (calculated) phosgene AEGL-2 value line at 4-h exposure are those of [@R27; @R28], and are considered biomarkers of exposure (decrease in lung ATP concentration in the rat; increased bronchiolar alveolar lavage fluid protein in the rat) with no known clinical significance. Thus, the published AEGL-2 values are already considered operationally protective. For comparison, if the 8-h AEGL-2 concentration \[0.04 ppm (0.16 mg/m^3^)\] is further down-adjusted by a factor of 2 *(i.e.*, 50%), the resulting concentrations \[0.02 ppm (0.08 mg/m^3^) for 8 h; 0.007 ppm (0.03 mg/m^3^) for 24 h\] fall below the concentrations at which [@R60] and [@R103] observed no clinically significant effects in rats, even when exposure durations extended over weeks *\[i.e.*, 0.1-ppm (0.4-mg/m^3^) phosgene, 6 h/d for 4 or 12 wk\].

In the absence of exposure guidelines for phosgene comparable to the AEGL-1, the present evaluation considered existing analyses published and judged scientifically credible by the NRC/COT; evaluated pertinent literature for extended exposure durations; and obtained professional counsel from recognized pulmonary toxicologists and investigators in the field. The following concentrations of phosgene in air as derived from the toxicological investigation of [@R85] can be considered health-protective estimates for use as remediation guidelines ([Table 2](#T2){ref-type="table"}) under the scenario parameters governing this assessment:

-   Exposure durations of \<8 h: 0.02 ppm CG (0.08 mg CG/m^3^).

-   Exposure durations of \>8 h but \<24 h: 0.007 ppm CG (0.03 mg CG/m^3^).

Comparison with human occupational ([@R58]) and laboratory animal ([@R40]; [@R27; @R28]; [@R60]; [@R103]) exposure data documents the protective nature of the above recommended exposure guidelines. Either no effects or minimal reversible effects were observed at greater concentrations *(e.g.*, 0.1 and 0.35 ppm phosgene). In the case of [@R58], workforce monitoring of approximately 200 phosgene processing workers over a period of 10 yr (at an average of 34 phosgene exposures/yr) determined that no signs or symptoms of phosgene toxicity were observed at repeated phosgene exposures at concentrations at least 5 times greater than the reasonable maximum value of 0.02 ppm CG (0.08 mg CG/m^3^) estimated above.

AGENT INGESTION GUIDELINES {#s10}
==========================

As indicated in the plots of liquid CWA persistence on airport interior media presented in the companion paper by [@R135], *this issue)*, it is highly unlikely that non-persistent CWAs will remain on surfaces after decontamination has been performed and verified. However, in cases where natural attenuation or degradation can be anticipated, consideration of surface values becomes extremely important. Post-release concerns could arise regarding the potential for persistent agents such as sulfur mustard or VX to present a continued source of exposure if liquid or aerosols droplets have been released. To meet potential waste-management determinations and landfill agreements with state and Federal agencies as well as stakeholder concerns regarding disposition of porous media as well as soils associated with horticultural plantings located within The Bradley International Terminal, reference dose (RfD) input to standard USEPA exposure models \[such as the USEPA Regional Screening Levels for Chemical Contaminants at Superfund Sites (RSLs) and Preliminary Remediation Goals (PRGs)\] was evaluated. These same models are often used to estimate protective concentration goals in water and food. Available concentration goals developed for chemicals of concern are provided here to assist pre-planning.

To facilitate such determinations when necessary, summarized in [Table 4](#T4){ref-type="table"} are available RfDs and reference dose estimates (RfD~e~) (in units of mg/kg/day) that have been previously developed and published ([@R92; @R93]; [@R122; @R123]) for the airport compounds of concern. Principal CWA degradation products of interest were previously identified in [@R135], *this issue);* available RfDs and RfD~e~ for the principal CWA degradation products are summarized in [Table 5](#T5){ref-type="table"}.

The CWA RfD estimates summarized in [Table 4](#T4){ref-type="table"} have been previously incorporated into standard USEPA models developed by Region 9 (PRG) and Region 3 \[Risk-Based Concentration (RBC) model\] ([@R112; @R113; @R115]) to develop agent-specific and health-based environmental screening levels ([@R108]; [@R130]). Resulting RBC and PRG values for airport scenario compounds are summarized in [Table 6](#T6){ref-type="table"}. For the purpose of the present analysis, Regional Screening Levels (RSLs) have also been estimated by application of the RSL calculator available at [@R120]; <http://www.epa.gov/reg3hwmd/risk/human/rb-concentration_table/usersguide.htm>). Because PRG, RBC and RSL models incorporate assumptions of continuous release and multi-year exposure durations, the health-based screening levels in [Table 6](#T6){ref-type="table"} are highly protective under the one-time, single-release airport scenario, which incorporates subsequent source removal and decontamination. PRG and RSL estimates incorporate consideration of chronic incidental soil ingestion as well as dermal contact with soil, and inhalation of particulates and vapors emitted from soil ([@R111; @R112; @R113; @R114]). Calculation of risk-based concentrations (RBCs) from the RBC model does not consider inhalation or dermal contact components, which are important to overall risk management analysis and final determination of acceptable clearance goals. As a consequence, RBC values are provided only for completeness.

###### 

Reference dose (RfD) and reference dose estimates (RfD~e~) for CWAs and TICs.[^a^](#T4FN1){ref-type="table-fn"}

  CWA or TIC                                                                                           Chronic Reference dose (RfD or RfD~e~) (mg/kg/day) Ingestion: estimate of daily exposure level for general population; chronic exposure duration (7 yr to lifetime)
  ---------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Tabun[^b^](#T4FN2){ref-type="table-fn"} (GA)                                                         4 × 10^−5^
  Sarin[^b^](#T4FN2){ref-type="table-fn"} (GB)                                                         2 × 10^−5^
  Soman[^b^](#T4FN2){ref-type="table-fn"} (GD) and Cyclosarin[^b^](#T4FN2){ref-type="table-fn"} (GF)   4 × 10^−6^
  VX[^b^](#T4FN2){ref-type="table-fn"}                                                                 6 × 10^−7^
  Sulfur mustard[^b^](#T4FN2){ref-type="table-fn"} (H/HD)                                              7 × 10^−6^
  Hydrogen cyanide[^c^](#T4FN3){ref-type="table-fn"} (AC)                                              0.02
  Cyanogen chloride[^d^](#T4FN4){ref-type="table-fn"} (CK)                                             0.05
  Phosgene[^e^](#T4FN5){ref-type="table-fn"} (CG)                                                      No estimate available[^e^](#T4FN5){ref-type="table-fn"}

^a^Adapted from [@R75] and [@R105].

^b^[@R93]. Values for nerve and sulfur mustard agents are estimates (RfD~e~) and considered scientifically valid by the National Research Council ([@R83]; [@R11]; they have not been formally reviewed by IRIS. The value for GF is also an RfD~e~ and has been developed by analogy to GD.

^c^[@R122].

^d^[@R123]. A comprehensive review of toxicological studies was completed in May, 2005; USEPA determined that results of review did not warrant a change in RfD at that time (<http://www.epa.gov/ncea/iris/subst>). CK also known as chlorine cyanide.

^e^IRIS (<http://www.epa.gov/iris/subst>) states that phosgene oral RfD was under discussion as of January 31, 2006. There has been no change in this determination as of August 2010.

The Regional Screening Level (RSL) application was released by the USEPA in late 2008; the RSL user guide disclaimer states that the RSL guidance is not mandatory, does not provide binding rules, and points out that alternative approaches for risk assessment may be more appropriate on a site-specific basis ([@R120], <http://www.epa.gov/reg3hwmd/risk/human/rb-concentration_table/usersguide.htm>). While originally developed by Regions 3, 6, and 9, the RSLs are presently (August 2010) accepted by many other USEPA regions. It is known that Preliminary Remediation Goals (PRGs) other than RSLs are in current use within all ten USEPA Regions, and reference to PRG use continues to be valid at this writing.

In 2004, USEPA Region 9 had developed PRG values for HCN and cyanogen chloride ingestion based on long-term (chronic) and direct ingestion of contaminated soil ([@R118]. The same PRG values are listed in the most recent regional screening level update ([@R119]) identified as an update of the USEPA Region 3 RBC Table, Region 6 HHMSSL (Human Health Medium-Specific Screening Levels) Table and the Region 9 PRG Table.

###### 

Principal CWA degradation products and their estimated RfD~e~.[^a^](#T5FN1){ref-type="table-fn"}

  Agent Parent (CAS number)           Key degradation product                                            Degradation Product CAS number   Chronic toxicity value[^b^](#T5FN2){ref-type="table-fn"} (estimated RfD~e~, in mg/kg/day)
  ----------------------------------- ------------------------------------------------------------------ -------------------------------- -------------------------------------------------------------------------------------------
  Tabun (GA) (77-81-6)                None of potential concern                                          \-                               \-
  Sarin (GB) (107-44-8)               Methyl phosphonic acid (MPA)                                       993-13-5                         0.02
                                      Isopropyl methylphosphonic acid (IMPA)                             1832-54-8                        0.10
  Soman (GD) (96-64-0)                Methyl phosphonic acid (MPA)                                       993-13-5                         0.02
    Cyclosarin (GF) (329-99-7)                                                                                                            
  VX (50782-69-9)                     S-(2-diisopropylaminoethyl) methylphosphonothioic acid (EA 2192)   73207-98-4                       6 × 10^−7^
                                      Ethyl methylphosphonic acid (EMPA)                                 1832-53-7                        0.028
                                      Methyl phosphonic acid (MPA)                                       993-13-5                         0.02
  Sulfur mustard (H, HD) (505-60-2)   Thiodiglycol (TDG)                                                 111-48-8                         0.400[^c^](#T5FN3){ref-type="table-fn"}

^a^Degradation products selected on basis of environmental persistence and/or toxicity; [@R105; @R106]), [@R75], [@R96], and [@R22].

^b^Unless otherwise noted, values were estimated by [@R13].

^c^[@R96].

###### 

Health-based environmental screening levels for CWAs and TICs in residential and industrial soils.[^a^](#T6FN1){ref-type="table-fn"}

                           Residential soil[^b^](#T6FN2){ref-type="table-fn"}                                Industrial soil                                                                                                  
  ------------------------ --------------------------------------------------------------------------------- ----------------- ------------- -------------------------------------------------------------------------------- -----
  Tabun (GA)               2.8 (est.)[^a^](#T6FN1){ref-type="table-fn"}                                      3.1               3.1           68 (est.)[^a^](#T6FN1){ref-type="table-fn"}                                      82
  Sarin (GB)               1.3 (est.)[^a^](#T6FN1){ref-type="table-fn"}                                      1.6               1.6           32 (est.)[^a^](#T6FN1){ref-type="table-fn"}                                      41
  Soman (GD)               0.22 (est.)[^a^](#T6FN1){ref-type="table-fn"}                                     0.31              0.31          5.2 (est.)[^a^](#T6FN1){ref-type="table-fn"}                                     8.2
  VX                       0.042 (est.)[^a^](#T6FN1){ref-type="table-fn"}                                    0.047             0.047         1.1 (est.)[^a^](#T6FN1){ref-type="table-fn"}                                     1.2
  Sulfur mustard (HD)      0.01 (est.)[^a^](#T6FN1){ref-type="table-fn"}[^c^](#T6FN3){ref-type="table-fn"}   0.55              0.55          0.3 (est.)[^a^](#T6FN1){ref-type="table-fn"}[^c^](#T6FN3){ref-type="table-fn"}   14
  Hydrogen cyanide(AC)     1.6 × 10^3d^                                                                      NA                1.6 × 10^3^   2.0 × 10^4d^                                                                     NA
  Cyanogen chloride (CK)   3.9 × 10^3d^                                                                      NA                3.9 × 10^3^   5.1 × 10^4d^                                                                     NA
  Phosgene (CG)            NA                                                                                NA                NA            NA                                                                               NA

^a^Derived and presented in [@R108] and [@R91] using EPA Region 3 model for RBC calculation, USEPA Region 9 model for PRG calculation, and agent-specific RfD estimates. Recent verification confirmed the protective nature of [@R108] derivations ([@R130]).

^b^May be used alone or in conjuction with vapor exposure criteria to assess possible existence of residual agent in semi-porous or porous media and to demonstrate potential for chemical agent being present in/on item or material at levels of public health concern. Useful for facilities and areas potentially exposed to extended high vapor or liquid concentrations ([@R32], Table C-5).

^c^Cancer-based; calculated from a target excess risk level of 10^−5^ for residential and 10^−4^ for industrial \[([@R108]; See also [@R130]\].

^d^EPA Regional Screening Levels for Chemical Contaminants ([@R119]) and EPA Region 9 PRG; values to be used as a screening goal or initial cleanup level. Considered protective for humans (including sensitive groups) over a lifetime. Guideline only, not regulation. EPA Region 9 "Regional Screening Levels for Chemical Contaminant at Superfund Sites, May 20, 2004" assumes soil ingestion only ([@R117; @R118]; Available at <http://www.epa.gov/region09/waste/sfund/prg/index.html>). See "Regional Screening Levels for Chemical Contaminants ..." ([@R119]; Available at <http://epa-prgs.ornl.gov/chemicals/>).

^e^For the purpose of the present analysis, Regional Screening Levels (RSLs) have also been estimated by use of the RSL calculator available at: [@R120]; see <http://www.epa.gov/reg3hwmd/risk/human/rb-concentration_table/usersguide.htm>). The resulting RSL estimates are identical to the above RBC (residential soil) values for nerve agents and sulfur mustard, and are identical to the above PRG (residential soil) values for hydrogen cyanide and cyanogen chloride. There are still no comparable values for phosgene.

###### 

Health-based environmental screening levels for principal CWA degradation products in residential and industrial soils and employing EPA PRG parameters.

                                       Residential soil   Industrial soil   
  ------------------------------------ ------------------ ----------------- -------------
  TDG (thiodyglycol)                   2.4 × 10^4^        6.0 × 10^4^       8.2 × 10^5^
  EMPA (ethyl methylphosphonic acid)   1.7 × 10^3^        4.2 × 10^3^       5.7 × 10^4^
  MPA (methyl phosphonic acid)         1.2 × 10^3^        3.0 × 10^3^       4.1 × 10^4^
  EA 2192                              4.7 × 10^−2^       6.8 × 10-^1^      1.2

^a^Derived and presented in [@R130]. PRG values to be used as a screening goal or initial cleanup level, and are considered protective for humans (including sensitive groups) over a lifetime. Guideline only, not regulation.

^b^May be used alone or in conjuction with vapor exposure criteria to assess possible existence of residual agent in semi-porous or porous media and to demonstrate potential for chemical agent being present in/on item or material at levels of public health concern. Useful for facilities and areas potentially exposed to extended high-concentration vapor or liquid concentrations ([@R32], Table C-5).

As of this writing, Region 9 maintains a link to the 2004 PRGs as well as providing RSLs. Analogous values have not been developed for phosgene. Separate PRGs that address either residential- or industrial-use scenarios ([Table 6](#T6){ref-type="table"}) are available from [@R118; @R119]) for hydrogen cyanide and cyanogen chloride.

RfD information for degradation products of interest has also been incorporated into PRG models to develop compound-specific degradation product concentration estimates for soil ([Table 7](#T7){ref-type="table"}). This approach could be employed to develop site-specific degradation product estimates for water and food in accordance with site-specific risk management criteria.

Drinking water concentrations considered protective estimates for the chemicals of concern and summarized as compound-specific concentrations in [Table 8](#T8){ref-type="table"} are developed from assumptions of a 5 or 15 liter/day drinking water consumption rate ([@R31; @R33]). Because most U.S. domestic drinking water consumption rate estimates for adults are ≤2 liter/day ([@R110]), the low drinking water concentrations resulting from an assumed 5 or 15-liter/day consumption rate are thus highly protective *(e.g.*, lower concentration associated with high-volume consumption) for application as general public decision criteria for water ingestion.

It is noted that subchronic RfDs for some persistent (illicit drug) compounds such as methamphetamine are being used by the California Environmental Protection Agency (CalEPA) Office of Environmental Health Hazard Assessment (OEHHA) ([@R100; @R101; @R102]) in determination of protective re-entry criteria to buildings formerly used as clandestine manufacturing facilities and that have undergone decontamination. This host-state example documents that subchronic RED estimates are recognized as useful and appropriate for specific screening level assessment applications and thus appropriate for the LAX scenario CWAs and TICs; [@R121] recognizes the utility of this approach by California regulatory authorities in developing a health-based target remediation standard for methamphetamine.

###### 

Drinking water concentrations considered protective estimates for site decontamination and verification.

                                     5 liter/day consumption[^a^](#T8FN1){ref-type="table-fn"}   15 liter/day consumption[^a^](#T8FN1){ref-type="table-fn"}
  ---------------------------------- ----------------------------------------------------------- ------------------------------------------------------------
  Tabun (GA)                         \<140                                                       \<46
  Sarin (GB)                         \<28                                                        \<9.3
  Soman (GD)                         \<12                                                        \<4
  VX                                 \<15                                                        \<5
  Generic nerve agent                \<12                                                        \<4[^b^](#T8FN2){ref-type="table-fn"}
  Sulfur mustard (HD)                \<140                                                       \<47
  Hydrogen cyanide (HCN; agent AC)   \<6                                                         \<2

^a^DOD Tri-Service standard for adult consumption rate of 5 and 15 liter/day, respectively, for exposure duration \<7 days ([@R31]). The most recent update to these Tri-Service standards ([@R33] makes no reference to the daily volume of water ingested and establishes the same concentrations presented above for 15 liter/day consumption as standard (e.g., no concentrations specific to 5 liters/day consumption). [@R33] further recommends application of the "Generic nerve agent" concentration of 4 μg/L for all nerve agents.

^b^"Generic nerve agent" water concentration standard equivalent to lowest concentration estimated for all nerve agents evaluated.

Oral Minimal Risk Levels (MRLs) are presently available only for sulfur mustard agent HD (MRL for acute-duration exposure of ≤14 d is 0.0005 mg HD/kg/d; MRL for intermediate-duration exposure of 15 to 364 d is 0.00007 mg/kg/d) ([@R8]), and may also be useful for specific screening assessments.

GUIDELINES FOR *IN-SITU* ITEMS {#s11}
==============================

Following a terrorist attack involving the release of a CWA or TIC, it may be necessary to decontaminate, handle, or otherwise manage large in-place items, such as X-ray scanners. It will also be necessary to manage numerous objects such as furniture and potentially contaminated samples. General guidance for sample handling is summarized on a compound-specific basis in recently published *Quick Reference Guides* for CWAs ([@R87]; available at [www.nrt.org](http://www.nrt.org)). The National Response Team cautions that sample packaging or shipping protocols should be closely coordinated with the receiving analytical laboratory.

The previously derived "Reasonable maximum re-entry screening guidelines" ([Table 2](#T2){ref-type="table"}; equivalent to the 8-h AEGL 1), may be used as appropriately protective and health-based vapor screening criteria for releasing items, equipment and facilities that have *not* been contaminated by liquid or aerosol forms of the chemicals of concern ([@R32], Table C-5). Further, these same screening criteria would also be useful to evaluate decontaminated non-porous items and surfaces, providing that vapor and surface screening criteria are attained ([@R32]).

For solid matrices, existing Health Based Environmental Screening Levels (mg/kg; HBESLs) as documented in [Table 6](#T6){ref-type="table"} for nerve and sulfur mustard agents are considered highly protective exposure criteria for lifetime (24-h) daily ingestion exposure by the general population (based on NOAEL; [@R108]; [@R130]). These criteria could be used alone or in parallel with vapor exposure criteria (see above) to assess potential existence of residual nerve or sulfur mustard agents within porous or semi-porous media at a level of public health insignificance. Such solid matrix decision criteria could be reasonably applied in the event of an extended high-concentration vapor or liquid exposure.

During World War I (WWI), the U.S. Government established an experimental facility (American University Experiment Station) in Spring Valley (in what was then rural Maryland) for testing and preparing chemical warfare compounds, incendiaries, smokes, and signal materials for use in battlefields ([@R147]). Protective clothing and equipment to counter use of such materials were also developed at the Spring Valley facility. The facility was closed at the end of the War, and agent-containing materials underwent disposal in various pits and trenches on-site. CWAs and TICs tested at the facility included vesicant agents sulfur mustard and Lewisite (an organic arsenical not included in the airport threat scenario), phosgene, cyanogen chloride, arsine, and chloropicrin. Nerve agents were not formulated until decades after WWI and are not an issue at Spring Valley ([@R94].

As a result of urban growth since the close of WWI, the former American University Experiment Station is now located within the District of Columbia. Protocols have recently been developed to guide sample and site clearance of soils, scrap, PPE, and bulk items recovered from the Spring Valley site in metropolitan Washington, D.C. ([@R94].

Criteria for the Spring Valley site and materials release involve warming a sample (15 min equilibration at 90 ± 10°F for soil; 4 h equilibration at 70 ± 10°F for scrap, PPE and bulk items); analyzing headspace offgas concentrations of HD, phosgene, and CK; then comparing offgas concentrations with agent-specific exposure limits (see below for specific values; Appendix J of [@R94]). Sample clearance determinations at Spring Valley are as follows (Appendix J of [@R94]):

-   If offgas concentrations are \<0.25 of the short term exposure limit (STEL) *(i.e.*, equal to 0.00075 mg/m^3^ for sulfur mustard, 0.10 mg/m^3^ for phosgene, and 0.15 mg/m^3^ for CK), the sample is cleared for disposal.

-   If offgas concentrations are \>0.25 of the STEL *(i.e.*, equal to 0.00075mg/m^3^ for sulfur mustard, 0.10 mg/m^3^ for phosgene, 0.15 mg/m^3^ for CK), then samples are reheated and allowed to equilibrate at the media-specific temperatures identified above, and re-sampled.

Application of the above guidelines would be useful in making clearance determinations involving problematic in-place items otherwise difficult (or destructive) to treat with aqueous solutions, foams, oxidizing vapors, and so on.

GUIDELINES FOR SURFACE CONTACT WITH POTENTIAL CWA AND DEGRADATION PRODUCT RESIDUES {#s12}
==================================================================================

Given the chemical and physical characteristics of the scenario compounds of concern \[[@R135], *this issue)*, [Table 2](#T2){ref-type="table"}\] and the efficacy of compound-specific decontamination materials and methods ([@R54]), it is unlikely that scenario CWA or TIC residues would exist on surfaces in quantities sufficient to pose a toxicological hazard after source removal and decontamination have been performed. Nevertheless, a contact hazard analysis that focuses on the persistent nerve agent VX and the persistent vesicant agent sulfur mustard (HD) has been performed to address stakeholder community requests for protective guidance regarding potential surface residues. The working assumption is that, in the unlikely event that exposed skin comes in contact with any residual compound of concern, the residue could be transferred to hands and subsequently carried to the eyes and mouth multiple times/day. Resuspension inhalation of particulates has also been considered. Exposure estimates, termed Surface Removal Contaminant Levels (SRCLs), have been developed and calculated so as to prevent development of a minimal and reversible effect threshold; SRCLs represent an estimated surface concentration in mass per unit area (mg/cm^2^). Specific parameters and assumptions are identified and characterized below.

For VX, the SRCL estimates are designed to prevent non-adverse levels of miosis (the first noticeable effect) in the absence of any other signs or measureable inhibition of blood cholinesterase activity. For HD, the SRCL estimates are designed to prevent mild reversible ocular irritation (the most sensitive endpoint and tissue).

Concepts and protocols considered by the USEPA dermal risk-assessment guidance ([@R116]) have been evaluated for application to the airport chemical terrorist release scenario. In addition, information from the World Trade Center (WTC) Indoor Assessment ([@R25] as well as the U.S. Army Man-in-Simulant Test (MIST) Program ([@R82] to calculate risk-based and site-specific concentrations for building interiors is also incorporated. Other sources contributing to the evaluation of acceptable residues on surfaces include agent-specific percutaneous toxicity data, concepts of acceptable residues and re-entry intervals developed by various state agencies and the USEPA for pesticide-treated crops, and exposure models under development by USEPA\'s National Exposure Research Laboratory ([@R104]; [@R146]; [@R23], among others). Concepts underlying risk-based criteria developed by CalEPA for use in assessing child potential exposure to surface methamphetamine residues in former clandestine laboratories ([@R100; @R101; @R102]) also contribute to the analyses. The equations used in this assessment are also based on the USEPA *Risk Assessment Guidance for Superfund* ([@R111]. The stochastic model approach developed by CalEPA was used for verification purposes in the present assessment. As data allow, and as recommended by CalEPA, compound-specific subchronic reference doses have been estimated for the scenario compounds and incorporated into the present calculation of SRCLs.

The same analytical procedure has been applied to previously identified, stable, agent-specific degradation products of toxicological concern, such as methyl phosphonic acid (MPA) and EA 2192 (potential hydrolysis product of agent VX, which occurs when pH is not adequately controlled during VX decontamination) ([@R67]; also [@R135], *this issue*, [Table 3](#T3){ref-type="table"}).

Estimated SRCLs for persistent CWAs and key degradation products are unique to the present analysis and are developed here as reasonable maximum exposure (RME) concentrations derived from standardized equations that combine exposure information and available compound-specific toxicity information. SRCLs are presented for child transit passengers (the most susceptible transit passenger subpopulation with expected maximal exposure to surface residues due to frequent object mouthing behavior and potential for large-area skin contact with airport terminal surfaces) as well as various airport employees and personnel. SRCLs presented here are protective risk-based screening values for use in evaluating surfaces that have (or may have) been in contact with HD or VX released during a chemical terrorist event, or degradation products of interest. SRCL analysis has been performed as a screening level assessment to protect against the unlikely event that airport surfaces have been incompletely decontaminated and inadequately sampled and monitored. It is suggested that SRCL results be used during post-decontamination monitoring to ascertain that surface contact hazards to chemical residues do not remain. Exceeding a SRCL usually suggests that further evaluation of the potential chemical risks is warranted, while attainment of SRCL levels would indicate that potential chemical risk is so low as to allow unprotected access to the terminal by the general public as well as various airport employees and personnel. In addition to utility as screening levels, SRCLs could also be used to trigger further investigation or serve as initial clearance goals for decision-makers.

Assumptions Regarding Percutaneous Contact with Residual Liquids or Aerosols {#s13}
----------------------------------------------------------------------------

The more volatile compounds on the scenario threat list (*e.g.*, the nonpersistent G-series nerve agents and the TICs phosgene, hydrogen cyanide, and cyanogen chloride) dissipate readily and pose much less risk of percutaneous contact or non-dietary ingestion exposure to deposited liquid or aerosol than the persistent CWA compounds HD and VX. Nevertheless, equations developed to evaluate persistent compounds can also be applied to provide highly protective estimates for the more volatile compounds.

It is understood that agents HD and VX will volatilize and degrade by known processes such as hydrolysis during the interval between the time of release and initiation of decontamination as well as during the interval between completion of decontamination and finalization of a clearance decision \[[@R135], *this issue)*, [Tables 2](#T2){ref-type="table"} through [4](#T4){ref-type="table"}; and [@R105])\]. To ensure protectiveness, known rates of volatilization and degradation are not factored into the SRCL equations.

The instability of liquid HCN \[[@R78]; [@R1]; [@R9; @R10]; [@R135], *this issue)*, [Table 2](#T2){ref-type="table"}\] indicates that HCN deposited as a liquid, or present as a residual aerosol, will not persist for more than a few minutes at ambient temperature. The possibility of direct percutaneous exposure to liquid or aerosolized HCN is also considered extremely low.

Assumed opportunities for exposure to a toddler child transit passenger would be from contacting hard surfaces (vinyl floors and chairs, desks, counters, walls, *etc.)* and soft surfaces (carpet, upholstered chairs, drapes, *etc)* with hands and other exposed skin. A fraction of any compound transferred to hands is assumed to be subsequently transferred to eyes and mouth. To develop a protective estimate, exposure assumptions for a toddler child transit passenger (the most susceptible population) have been selected as representative of the entire transit passenger population. Further, any potential adult airport employee/personnel exposure is assumed to occur during contact with hard or soft surfaces such as carpets, counters, drapes, seating, walls, and ceilings during post-decontamination activities.

Because the eye is extremely sensitive to the effects of HD and VX vapor and liquid ([@R86]), contact hazard equations focus on consideration of eye exposure to estimate the most protective SRCL. This is a unique aspect of the current assessment, as direct eye exposure is not commonly evaluated in surface contact assessments. Agent-specific eye contact (ocular) toxicity values were not available in the literature; as a consequence, dermal toxicity values for skin were substituted, and 100% transfer from hand to eye was assumed; this approach is considered protective.

Media that can be sampled for comparison to the SRCLs could range from agentladen dust to any surface films transferable to a sample wipe or surface probe.

Surface Exposure Parameters {#s14}
---------------------------

Exposure parameters, variables, and values incorporated into the SRCL model equations for agents HD and VX, as well as HD and VX degradation products, are identified and characterized in [Tables 9](#T9){ref-type="table"} and [10](#T10){ref-type="table"}. To account for variability in likely exposure scenarios, estimates are presented for the average and maximum anticipated exposures. Such an analysis replicates many of the assumptions employed in the WTC assessment for indoor environments ([@R25]). A notable deviation from the WTC assessment is the fact that the present SRCL equations do not include a dissipation factor for surface residues. Instead, the present analysis incorporates agent degradation rates previously summarized in [@R135], *this issue)* to evaluate SRCL-specific exposure durations and frequencies. Calculations in [@R135], *this issue;* [Table 4](#T4){ref-type="table"} and Figure 6) illustrate that multiple degradation half-lives for VX and HD can be achieved in less than 2 d following application of appropriate decontamination solutions. In the case of the present analysis, selection of values for ED and EF are based on well-characterized and rapid degradation generated during the preceding decontamination phase. Hence, the SRCL equations do not include a decay/dissipation rate. While traditional exposure assessments have been based on consideration of human activity patterns and not the presence/absence of contamination ([@R111]), rapid agent degradation generated during the decontamination phase directs the selection of ED and EF values in the present analysis.

###### 

Exposure parameter assumptions for HD and VX incorporated into SRCL assessment.[^a^](#T9FN1){ref-type="table-fn"}

  Parameter               Estimated airport average   Estimated airport maximum   Units
  ----------------------- --------------------------- --------------------------- -------------
  ABS~HD~                 0.084                       0.084                       Unitless
  ABS~VX~                 0.033                       0.033                       Unitless
  BW~W~                   70                          70                          Kg
  BW~C~                   15                          15                          Kg
  CF1                     3.65E+02                    3.65E+02                    days/year
  CF2                     0.041667                    0.041667                    days/hour
  CF3                     10000                       10000                       cm^2^/m^2^
  DF work HD              285                         427.5                       cm^2^/day
  DF work VX              8.075                       12.1125                     cm^2^/day
  DF trans child HD       70.0                        420                         cm^2^/day
  DF trans child VX       1.98                        11.9                        cm^2^/day
  ED work                 1                           1                           Years
  ED child                1                           1                           Years
  EF work                 2                           2                           days/year
  EF trans (child)        2                           2                           day/year
  ETh child               2                           12                          hours/day
  ETh work                4                           6                           hours/day
  ETs work                4                           6                           hours/day
  ETs child               2                           12                          hours/day
  FQ~c~                   9.5                         9.5                         events/hour
  FQ~eye~                 10                          10                          event/day
  FQ~work~                1                           1                           event/hour
  FTSHSh HD               0.5                         0.5                         Unitless
  FTSHSh VX               0.0018                      0.0018                      Unitless
  FTSHSs HD               0.1                         0.1                         Unitless
  FTSHSs VX               0.0152                      0.0152                      Unitless
  FTSBSh HD               0.25                        0.25                        Unitless
  FTSBSh VX               0.0009                      0.0009                      Unitless
  FTSBSs HD               0.05                        0.05                        Unitless
  FTSBSs VX               0.0076                      0.0076                      Unitless
  GIABS HD&VX             1                           1                           Unitless
  IF work HD              54                          81                          cm^2^/day
  IF work VX              1.53                        2.295                       cm^2^/day
  IF trans HD             85.5                        513                         cm^2^/day
  IF trans VX             2.4225                      14.535                      cm^2^/day
  OF work HD              33.4                        50.1                        cm^2^/day
  OF work VX              0.9463                      1.4195                      cm^2^/day
  OF trans HD             16.7                        100.2                       cm^2^/day
  OF trans VX             0.47                        2.839                       cm^2^/day
  RF                      1.00E-06                    1.00E-06                    m-^1^
  RfD est. subchron HD    7.00 E-05                   7.00 E-05                   mg HD/kg/d
  RfD est. subchron VX    2.00 E-06                   2.00 E-06                   mg VX/kg/d
  SA eyes                 33.4                        33.4                        cm^2^/event
  SA trans exposed skin   2800                        2800                        cm^2^/day
  SA trans hand           15                          15                          cm^2^/event
  SA work exposed skin    5700                        5700                        cm^2^/day
  SA work hand            45                          45                          cm^2^/event
  SE                      0.5                         0.5                         Unitless
  THQ                     1                           1                           Unitless
  AT nc                   365∗ED                      365∗ED                      Days

^a^Variables: dermal absorption factor (ABS), averaging time (AT), body weight (BW), conversion factor (CF~1-3~), dermal factor (DF), exposure duration (ED), exposure frequency (EF), exposure time (ET), frequency of hand-to-mouth for child (FQ~c~), frequency of hand-to-eye (FQ~eye~), fraction transferred from surface to body skin (FTSBS), fraction transferred from surface to hand skin (FTSHS), gastrointestinal absorption factor (GIABS), ingestion factor (IF), ocular rubbing factor (OF), resuspension factor (RF), reference dose (RfD), hand surface area (SA~hand~), exposed skin surface area (SA~trans~ and SA~work~), eye surface area (SA~eye~), saliva extraction factor (SE), target hazard quotient (THQ); "c" and "w" modifers refer to child transit passenger and various airport employees and personnel (worker), respectively; "s" and "h" modifiers refer to soft and hard surfaces, respectively; "nc" refers to non-cancer. See text for definitions and assumptions.

Illustrated in [Figure 1](#F1){ref-type="fig"} are the SRCL equation and calculation for estimating VX effects for toddler child (sensitive receptor) transit passengers; in [Figure 2](#F2){ref-type="fig"} are presented the comparable VX SRCL model equation and calculation for airport employees and personnel. While nerve agent VX was chosen as the example calculation for [Figures 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}, the user can substitute HD- or degradation product-specific parameters as needed. Presented in [Figure 3](#F3){ref-type="fig"} is a conceptual site model of potential exposure pathways evaluated for surfaces (as modeled in [Figures 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}) as well as direct and offgas vapor exposure.

Exposure time (ET) {#s15}
------------------

Exposure time (ET) for this surface analysis represents the estimated hours per day that a receptor spends in contact with potentially contaminated media. In general, exposure times vary by exposure scenario, age of the receptor, and whether the source is located on a hard or soft surface. Most ET data and USEPA default values for children \[[@R25] and the USEPA Office of Pesticide Programs (OPP)\] have been experimentally determined from USEPA observational studies characterizing the time spent by child residents per day in the kitchen and bathroom. Estimates of carpet exposure time are based on remaining indoor time, excluding sleeping. The World Trade Center assessment ([@R25]) judged these data to be representative of many children under age 6 who spend most of their time at home. It is acknowledged that potential exposures at an airport would not be representative of at-home exposures in terms of activity and duration, and that data characterizing time spent on hard and soft surfaces at airports are not available.

###### 

Exposure parameter assumptions for significant HD and VX breakdown products incorporated into SRCL assessment.

  Parameter                  Estimated airport average   Estimated airport maximum   Units
  -------------------------- --------------------------- --------------------------- ----------------
  ABS~TDG~                   0.009                       0.009                       Unitless
  ABS~EMPA~                  0.084                       0.084                       Unitless
  ABS~MPA~                   0.084                       0.084                       Unitless
  ABS~EA2192~                0.0                         0.0                         Unitless
  DF trans child TDG         70                          420                         cm^2^/day
  DF trans child EMPA        70                          420                         cm^2^/day
  DF trans child MPA         70                          420                         cm^2^/day
  DF trans child EA2192      1.98                        11.9                        cm^2^/day
  FTSHSh TDG                 0.5                         0.5                         Unitless
  FTSHSh EMPA                0.5                         0.5                         Unitless
  FTSHSh MPA                 0.5                         0.5                         Unitless
  FTSHSh EA2192              0.0018                      0.0018                      Unitless
  FTSHSs TDG                 0.1                         0.1                         Unitless
  FTSHSs EMPA                0.1                         0.1                         Unitless
  FTSHSs MPA                 0.1                         0.1                         Unitless
  FTSHSs EA2192              0.0152                      0.0152                      Unitless
  FTSBSh TDG                 0.25                        0.25                        Unitless
  FTSBSh EMPA                0.25                        0.25                        Unitless
  FTSBSh MPA                 0.25                        0.25                        Unitless
  FTSBSh EA2192              0.0009                      0.0009                      Unitless
  FTSBSs TDG                 0.05                        0.05                        Unitless
  FTSBSs EMPA                0.05                        0.05                        Unitless
  FTSBSs MPA                 0.05                        0.05                        Unitless
  FTSBSs EA2192              0.0076                      0.0076                      Unitless
  IF trans TDG               85.5                        513                         cm^2^/day
  IF trans EMPA              85.5                        513                         cm^2^/day
  IF trans MPA               85.5                        513                         cm^2^/day
  IF trans EA2192            2.4225                      14.5                        cm^2^/day
  OF trans TDG               16.7                        100.2                       cm^2^/day
  OF trans EMPA              16.7                        100.2                       cm^2^/day
  OF trans MPA               16.7                        100.2                       cm^2^/day
  OF trans EA2192            0.47                        2.839                       cm^2^/day
  RfD est. subchron TDG      4.00E+00                    4.00E+00                    mg TDG/kg/d
  RfD est. subchron EMPA     2.80E-01                    2.80E-01                    mg EMPA/kg/d
  RfD est. subchron MPA      2.00E-01                    2.00E-01                    mg MPA/kg/d
  RfD est. subchron EA2192   2.00E-06                    2.00E-06                    mg EA2192/kg/d
  RfC est. subchron TDG      4.70E+00                    4.70E+00                    mg TDG/m^3^
  RfC est. subchron EMPA     3.40E-01                    3.40E-01                    mg EMPA/m^3^
  RfC est. subchron MPA      2.40E-01                    2.40E-01                    mg MPA/m^3^
  RfC est. subchron EA2192   0.00E+00                    0.00E+00                    mg EA2192/m^3^

Variables: See footnote to [Table 9](#T9){ref-type="table"}.

To more closely represent the non-resident characteristics of the airport chemical terrorist scenario, it was necessary to depart from use of generic default exposure parameters *(e.g.*, child resident defaults are 8 h/day for carpets and 4 h/day for hard surfaces) ([@R25]). As a consequence, this analysis divided the exposure to hard and soft surfaces equally for a full 24 h *(e.g.*, 12 h for hard and 12 h for soft). The duration that a passenger spends in a terminal is designated as the "dwell time" or stay time ([@R20]). The Center for Airport Management ([@R20]) data revealed that the total dwell time for most passengers is ≤4 h. Because the time spent in a terminal in one day can vary greatly, an average, minimum total ET to hard and soft surfaces is estimated to be 4 h *(e.g.*, 2 h for soft surface exposure plus 2 h for hard surface exposure), and the maximum is estimated to be 24 h (to accommodate long layovers and delays) *(e.g.*, 12 h each for soft and hard surface exposures).

![Airport transit passenger toddler SRCL estimate for VX (see [Table 9](#T9){ref-type="table"} for CWA-specific parameters).](bher17-57_f1){#F1}

![Airport employee and personnel SRCL for VX (see [Table 9](#T9){ref-type="table"} for CWA-specific parameters).](bher17-57_f2){#F2}

![Conceptual site model of potential exposure pathways evaluated.](bher17-57_f3){#F3}

[@R25] does not provide information on WTC generic employee exposures to hard and soft surfaces. Because of the high variability of potential surface contact for airport employees and personnel, surface exposure time is also divided equally between exposure to hard and soft surfaces in the current analysis. Furthermore, because the workday length can vary, an average total workday ET to hard and soft surfaces was estimated to be 8 h (regular work shift), and the maximum is estimated to be 12 h. The same work shift assumptions are used by the CDC ([@R37; @R38]) and [@R114].

Exposure duration (ED) {#s16}
----------------------

The equations in [Figures 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"} were developed for this analysis and for non-carcinogenic effects. These equations are consistent with examination of compound-specific toxicological data that indicate diminishing toxic response and effects recovery following cessation of exposure. In non-cancer effect PRG equations, the exposure duration (ED) in the numerator multiplied by 365 days per year represents the time over which exposure is averaged. The ED in the denominator multiplied by the exposure frequency represents the time of exposure. Dividing the numerator by the denominator "pro-rates" the exposure ([@R110]).

Exposure durations between 2 weeks and less than 7 years are considered subchronic, while exposure durations greater than 7 years are considered chronic ([@R110]). For the transit passenger receptor as well as airport employee/personnel receptors, an ED of one year is selected for the present analysis. This ED is based on the degradation analysis performed in the first paper of this series ([@R135], *this issue;* [Table 4](#T4){ref-type="table"} and Figure 6), which illustrates that multiple degradation half-lives for persistent agents VX and HD can be achieved in less than 2 days following application of appropriate decontamination solutions. Note that an exposure duration of 1 year is the smallest exposure duration presented in [@R110] for standard risk equations.

It is recognized that most exposure parameters have been traditionally based on human activity patterns and not the presence/absence of contamination ([@R111]). In the case of a transit passenger, it is possible that, during a single round trip, a passenger would pass through the same terminal during a single year. Also, it is acknowledged that, without appropriate consideration of the decontamination phase and well-characterized degradation reactions previously discussed ([@R135], *this issue;* [@R105]; [@R142]; [@R141]; many others), some investigators may unknowingly consider setting the ED for an airport employee as high as the EPA-recommended default of 25 years. Previous characterization of the agent release and response scenario ([@R135], *this issue)* precludes the necessity of relying on default values. With appropriate decontamination and treatment, a persistent compound from the airport scenario threat list can pose a nonpersistent hazard in that any residual contamination can be quickly degraded. No chronic exposure duration *\[e.g.*, \> 7 years as per ([@R111])\] is assumed.

Exposure frequency (EF) {#s17}
-----------------------

Exposure frequency (EF) is the number of days within the ED that exposure is assumed to occur. Based on human activity, it is reasoned that a single round-trip transit passenger may be exposed to potentially contaminated surfaces in the same terminal for a maximum of 2 days during a single round trip (the first day for trip departure, and the second day for the trip return). Additionally, and based on the ED discussion above and calculations in [@R135], *this issue;* [Table 4](#T4){ref-type="table"} and Figure 6) illustrating that multiple degradation half-lives for VX and HD are achieved in less than 2 days following application of appropriate decontamination solutions, an EF of 2 days/year was selected for the transit passenger. No chronic exposure is assumed

The EF assumptions for airport employees and personnel mirror those of the transit passengers *(e.g.*, no repeat exposure cycles). An EF of 2 days/year was selected for various airport employees and personnel based on the degradation analysis above and in [@R135], *this issue).*

Fraction transferred from surface to hand skin (FTSHS) {#s18}
------------------------------------------------------

The FTSHS is the fraction of residue on a surface that could be transferred to the skin of the hand. Hand-press experiments with house-dust surrogate particles were conducted to measure surface transfer to dry skin ([@R99]). Based on [@R99], the WTC report ([@R25]) recommended use of default transfer fractions of 10% for carpets and 50% for hard surfaces (such as vinyl). In addition, [@R25] references an USEPA Malathion® exposure study that reported Malathion^®^ transfer-to-hand results of 0.0018 (0.18%) and 0.0152 (1.52%) for vinyl flooring and carpets, respectively. Malathion® (C~10~H~19~O~6~PS~2~) is an organophosphate insecticide that is physically similar to nerve agent VX (C~11~H~26~NO~2~PS) in many respects (vapor pressures of VX and malathion are 7 × 10^−4^ and 1.78 × 10^−4^ mm Hg, respectively, while Henry\'s Law constants for VX and malathion are 3.5 × 10^−9^ and 4.9 × 10^−9^ atm-m^3^/mole, respectively) ([@R86]; [@R36]; [@R42]). It is thus reasonable to apply the Malathion^®^-specific FTSHS fractions provided in [@R25] for use in estimating a value for VX. Due to the unavailability of HD-specific transfer rates, the assumed FTSHS fractions for HD are the generic defaults recommended by [@R25] of 10% for soft and 50% for hard surfaces.

Fraction transferred from surface to body skin (FTSBS) {#s19}
------------------------------------------------------

In terms of the fraction transferred from surface to body skin (FTSBS) for dermal contact, it is important to consider that, in comparison to hands, much less transfer will occur to body regions such as the arms, legs, and face that have typically less intensive surface contact. In accordance with assumptions made in the WTC report ([@R25]), fractions for surface-to-hand transfer were reduced by half to represent an area-weighted transfer to all exposed body skin.

Hand surface area (SA~hand~) {#s20}
----------------------------

Hand surface area (SA ~hand~) is the skin area contacted during a mouthing event. The WTC report ([@R25]) assumes that the finger area used for hand-to-mouth transfer varies linearly from 15 cm^2^ for a 2-year-old child, to 45 cm^2^ at age 17, and remains constant thereafter throughout adulthood.

Exposed skin surface area (SA~trans~ and SA~work~) {#s21}
--------------------------------------------------

For dermal contact, it is important to consider that much less transfer will occur to body parts such as the arms, legs, and face that undergo less intensive surface contact than hands. This analysis follows Superfund exposure assessment guidance, which has established exposed skin surface areas (SA~trans~ and SA~work~) as 2800 cm^2^ for clothed children and 5700 cm^2^ for clothed adult workers ([@R116]).

Frequency of hand-to-mouth contact (FQ) {#s22}
---------------------------------------

Based on observations at day-care centers and the literature ([@R66]), the WTC report ([@R25]) groups the age cohort-specific hand-to-mouth contact frequency (FQ) as follows: toddler child (1 to 6 yr; FQ~c~) = 9.5 times/h; adult (≥18 yr; FQ~a~) = 1 time/h.

Saliva extraction factor (SE) {#s23}
-----------------------------

The fraction transferred from skin to mouth depends on the contaminant, mouthing duration, and other behavioral patterns. The WTC assessment used the USEPA Office of Pesticide Programs (OPP) default of 50%, based on pesticide studies ([@R25]). [@R66] assumed that all of the residues deposited on the fingertips would be transferred to the mouth, twice per day. In the Binghamton State Office Building post-fire re-entry guideline derivation, a range of factors was used: 0.05, 0.1, and 0.25, representing the fraction of residue on the hand that is transferred to the mouth ([@R59]). For purposes of the airport evaluation, the OPP default of 50% used in the WTC assessment was selected as the saliva extraction factor (SE) for all ages.

Ingestion factor (IF) {#s24}
---------------------

To account for variability in exposure to hard and soft surfaces, the WTC assessment developed a dust ingestion factor (IF) equation ([@R25]). This equation averages the differences in exposure to hard and soft surfaces by the exposure times. The following generic equation is presented below without scenario-specific inputs ([Table 9](#T9){ref-type="table"} for variable identification and characterization). This equation applies to toddler child transit passengers as well as various airport employees and personnel: $$\text{IF}\left( \frac{\text{cm}^{\text{2}}}{\text{day}} \right) = \left( {\left\lbrack {\left( {\text{FTSH}_{\text{h}} \times \text{ET}_{\text{h}}\left( \frac{\text{hrs}}{\text{day}} \right)} \right) + \left( {\text{FTSHS}_{\text{s}} \times \text{ET}_{\text{s}}\left( \frac{\text{hrs}}{\text{day}} \right)} \right)} \right\rbrack \times \text{SE} \times \text{SA}_{\text{hand}}\left( \frac{\text{cm}^{\text{2}}}{\text{event}} \right) \times \text{FQ}_{\text{trans}}\left( \frac{\text{event}}{\text{hours}} \right)} \right)$$

Dermal factor (DF) {#s25}
------------------

To account for variability in exposure to hard and soft surfaces, the WTC assessment developed a dermal absorption factor (DF) equation ([@R25]). This equation averages the differences in exposure to hard and soft surfaces by the exposure durations ([Table 9](#T9){ref-type="table"} for variable identification and characterization). As for the ingestion factor, the following generic equation is presented without scenario-specific inputs and is applied to toddler child transit passengers as well as various airport employees and personnel: $$\text{DF}\left( \frac{\text{cm}^{\text{2}}}{\text{day}} \right) = \left( {\left\lbrack {\left( {\text{FTSBS}_{\text{h}} \times \text{ET}_{\text{h}}\left( \frac{\text{hrs}}{\text{day}} \right)} \right) + \left( {\text{FTSBS}_{\text{s}} \times \text{ET}_{\text{s}}\left( \frac{\text{hrs}}{\text{day}} \right)} \right)} \right\rbrack \times \text{SA}_{\text{trans}}\left( \frac{\text{cm}^{\text{2}}}{\text{day}} \right) \times \left( \frac{\text{1day}}{\text{24hrs}} \right)} \right)$$

Frequency of hand-to-eye (FQ~eye~) {#s26}
----------------------------------

Because the eye is the most sensitive body part for exposure to HD and VX ([@R86]), this evaluation follows the WTC model concept of hand-to-mouth contact by developing and adding a hand-to-eye exposure route. Consideration of hand-to-eye exposure is a unique feature of the SRCL model approach. A literature search was performed to determine hand-to-eye contact frequency (FQ~eye~).

Sensitive populations, such as contact lens wearers, allergy sufferers, and people with the medical condition keratoconus, were not excluded. [@R64] report that subjects without contacts and without any eye abnormality usually lightly rub their eyes for a short time with the pads of their fingers at a frequency of less than once per day. Subjects with kerataconus use their knuckles and aggressively grind the eye socket with multiple, prolonged episodes each day.

[@R145] noted that, out of 64 subjects with vernal keratoconjunctivitis, 66% rubbed their eyes frequently (\>10 times daily), 24% rubbed their eyes occasionally (5 to 10 times daily), and 10% rubbed their eyes rarely (\<5 times daily). [@R21] questioned 44 patients who reported either frequent (\>10 times/day), occasional (5 to 10 times/day) or rare (1 to 4 times/day) eye rubbing. [@R61] found that prolonged, forceful, multiple-knuckle eye rubbing occurs 3 to 10 times per day in patients with kerataconus, whereas control group frequency is less than once per day and is manifest by application of finger tips and a brief, light rubbing. For the purposes of the present evaluation, the threshold for "frequent" *(e.g.*, 10 times/day) hand-to-eye rubbing reported in these studies was used. It is also assumed that hand-to-eye contact could also occur without a rubbing episode. Because of the deep pressure applied to the eye during a kerataconus eye-rubbing episode and the normal moisture present around the eye, it was assumed for the purpose of the present assessment that 100% of a contaminant on the fingers and hand would be transferred to the eye during a rubbing episode.

Eye surface area (SA~eye~) {#s27}
--------------------------

The surface area of the eye (SA~eye~) is needed to calculate this exposure route. The studies reported in the earlier assessment of hand-to-eye contact frequency (FQ~eye~) report that both eyes are often rubbed at the same time. Data from literature ([@R18]) allowed calculation of the combined surface area of both eyes (33.4 cm^2^). The exposed eye surface between the upper and lower eyelids is elliptical, and the standard formula for elliptical area is employed; the long axis estimate is 32.6 mm (palpebral fissure length); the short axis estimate is 16.3 mm (palpebral fissure height of 10.3 mm added to 3 mm each for upper and lower eyelids) ([@R18]).

Ocular rubbing factor (OF) {#s28}
--------------------------

To account for variability in hand exposure to hard and soft surfaces, an ocular rubbing factor (OF) equation was developed for the current analysis. The following equation (see [Table 9](#T9){ref-type="table"} for variable identification and characterization) averages differences in hand exposure to hard and soft surfaces, and consequent differences in potential contaminant exposure to the eye: $$\text{OF}\left( \frac{\text{cm}^{\text{2}}}{\text{day}} \right) = \left( {\left\lbrack {\left( {\text{FTSHS}_{\text{h}} \times \text{ET}_{\text{h}}} \right) + \left( {\text{FTSHS}_{\text{s}} \times \text{ET}_{\text{s}}} \right)} \right\rbrack \times \text{SA}_{\text{eyes}}\left( \frac{\text{cm}^{\text{2}}}{\text{event}} \right) \times \text{FQ}_{\text{eye}}\left( \frac{\text{event}}{\text{day}} \right) \times \left( \frac{\text{1day}}{\text{24hrs}} \right)} \right)$$

Resuspension factor (RF) {#s29}
------------------------

It is possible that agent may be resuspended in dust from a contaminated surface by the action of foot traffic and cleaning activities ([@R48]). Reports of the U.S. Nuclear Regulatory Commission ([@R89; @R90]) present resuspension factors (relating air concentration to surface concentration) ranging from 6 × 10^−8^ to 7 × 10^−4^ m^−1^ for multiple activities. Based on the NUREG (2002) recommendations, an intermediate resuspension factor (RF) of 1 × 10^−6^ m^−1^ was selected as a representative default RF for the airport scenario analysis.

Dermal absorption factor (ABS) {#s30}
------------------------------

Dermal absorption factor (ABS) represents the unitless fraction of potential contaminant that could be transferred through the skin for systemic absorption from contaminated media. Dermal absorption factor values of 0.056 for HD and 0.022 for VX have been used for CW agent demilitarization facility personnel estimates, while ABS values of 0.084 for HD and 0.033 for VX have been used in calculating residential estimates ([@R108]. The residential ABS values from [@R108] were incorporated into the present analysis. For nerve agent VX, the ABS value of 0.033 compares well with results of *in vitro* experimental absorption on human cadaver skin samples exposed to ^14^C parathion, an anticholinesterase insecticide considered to be a reasonable surrogate for nerve agent VX ([@R137]). Following a single exposure and a 96-h absorption period, 1.78 ± 0.41% (e.g., 0.018) of the labeled parathion was taken up by unclothed, dry cadaver skin samples ([@R137]).

The present analysis compared SRCL values resulting from inclusion of the ABS value of 0.033 for a residential scenario (a protective assumption for the airport assessment; [@R108]) versus the ABS estimate of 0.018 taken from [@R137]. The SRCL results from both calculations equal 3.1 × 10^−4^ mg/cm^2^ for the 24-h exposure duration ([Tables 11](#T11){ref-type="table"} and [12](#T12){ref-type="table"}).

###### 

Estimated Sulfur Mustard and Agent VX Surface Removal Contaminant Levels (SRCLs) for child transit passengers.[^a^](#T11FN1){ref-type="table-fn"}

  CWA                   Transit Passenger SRCL~4~[^b^](#T11FN2){ref-type="table-fn"}[^c^](#T11FN3){ref-type="table-fn"} Protective estimate (mg/cm^2^ surface, continuous exposure)   Transit Passenger SRCL~24~[^b^](#T11FN2){ref-type="table-fn"}[^d^](#T11FN4){ref-type="table-fn"} Protective estimate (mg/cm^2^ surface, continuous exposure)
  --------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------
  Sulfur mustard (HD)   1.77 × 10^−3^                                                                                                                                                 2.95 × 10^−4^
  VX                    1.85 × 10^−3^                                                                                                                                                 3.08 × 10^−4^

^a^Chemical formulae: HD, C~4~H~8~Cl~2~S; VX, C~11~H~26~NO~2~PS.

^b^The "child passenger" estimate employs toddler child-specific information regarding object mouthing behavior and dermal contact with surfaces, and is thus a protective estimate for adult transit passengers. Passenger SRCL estimates incorporate contaminant transfer from hard and soft surfaces to the eye, skin, and mouth (incidental ingestion) as well as potential particle inhalation arising from resuspension.

^c^SRCL~4~ assumes average exposure dwell time of 4 continuous h (incorporates inhalation toxicity value for exposure durations ≤8 h).

^d^SRCL~24~ assumes maximal exposure dwell time of 24 continuous h (incorporates inhalation toxicity value for exposure durations \>8 h but ≤24 h).

###### 

Estimated Sulfur Mustard and Agent VX Surface Removal Contaminant Levels (SRCLs) for adult airport employees and personnel.[^a^](#T12FN1){ref-type="table-fn"}

  CWA                   Airport Employee/Personnel SRCL~8~[^b^](#T12FN2){ref-type="table-fn"}[^c^](#T12FN3){ref-type="table-fn"} Protective estimate (mg/cm^2^ surface, CWA continuous exposure)   Airport Employee/Personnel SRCL~12~[^b^](#T12FN2){ref-type="table-fn"}[^d^](#T12FN4){ref-type="table-fn"} Protective estimate (mg/cm^2^ surface, continuous exposure)
  --------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Sulfur mustard (HD)   8.65 × 10^−3^                                                                                                                                                              5.77 × 10^−3^
  VX                    9.56 × 10^−3^                                                                                                                                                              6.33 × 10^−3^

^a^Chemical formulae: HD, C~4~H~8~Cl~2~S; VX, C~11~H~26~NO~2~PS.

^b^Airport employee estimate includes various airport employees and personnel (all of whom are restrained from entering the facility until after the agent source is removed or neutralized, any decontamination process is completed, and monitoring has characterized workspace atmospheres as suitable for reoccupancy). Airport employee and personnel SRCL estimates incorporate contaminant transfer from hard and soft surfaces to the eye, skin, and mouth (incidental ingestion) as well as potential particle inhalation due to resuspension.

^c^SRCL~8~ assumes average exposure time (shift) of 8 continuous h (incorporates inhalation toxicity value for exposure durations ≤8 h).

^d^SRCL~12~ assumes maximal exposure time (shift) of 12 continuous h (incorporates inhalation toxicity value for exposure durations \>8 h but ≤24 h).

Body weight (BW) {#s31}
----------------

Body weights (BWs) of 70 kg and 15 kg were assumed for adults and children, respectively ([@R116]).

Gastrointestinal absorption factor (GIABS) {#s32}
------------------------------------------

Gastrointestinal absorption factors (GIABSs) are commonly used to convert oral toxicity values into dermal toxicity values because dermal toxicity values are seldom available; such conversions are considered protective. The GIABS is the unitless fraction of contaminant absorbed in the gastrointestinal tract. When applied to dermal toxicity estimates, use of the GIABS maximizes the dermal absorption estimate by assuming that GI tract and skin absorption are equal for a given compound. The following equation from [@R116] illustrates how to convert an oral RfD to a dermal RfD. GIABS values of 1 were used for both HD and VX because chemical-specific values were not available; this is a highly protective assumption. $$\text{RfD}_{\text{dermal}} = \text{RfD}_{\text{oral}} \times \text{GIABS}$$

SRCL Results for Agents HD and VX {#s33}
---------------------------------

Summarized in [Tables 11](#T11){ref-type="table"} and [12](#T12){ref-type="table"} are HD and VX results for the assumed average and maximum (24-h) exposure times for a child transit passenger and adult airport employees and personnel, respectively. For any given airport population and dwell time evaluated, there is little nominal difference between the estimated SRCLs for agents HD and VX, despite the large differences in toxicity values included in the calculation ([Tables 11](#T11){ref-type="table"} and [12](#T12){ref-type="table"}). This "flattening" of compound-specific differences is a result of the choice of values selected to characterize the fraction transferred from surfaces to skin of the hand or body in the equations employed. Values selected for nerve agent VX estimation are those for the organophosphate insecticide Malathion®, being considered here as a surrogate for nerve agent VX due to previously identified similarities in the physical characteristics of vapor pressure and Henry\'s Law Constants (see earlier characterization of FTSHS) ([@R86]; [@R36]; [@R42]). It is thus reasonable to apply Malathion^®^-specific fractions (transfer-to-hand fraction of 0.0018 and 0.0152 for vinyl flooring and carpets, respectively; [@R25]) for use in VX characterization during the current evaluation.

In contrast, those skin transfer values employed for sulfur mustard are standard defaults originally developed for particle transfer (10% for carpets, and 50% for hard surfaces such as vinyl) as recommended by [@R25], and from hand-press experiments by [@R99]. The use of default skin transfer values for HD is due to the unavailability of HD-specific (or reasonable surrogate-specific) hard- and soft-surface skin-transfer data for this vesicant agent; this is a significant data gap. The chemical and physical properties of sulfur mustard agent HD \[[@R135], *this issue)*, [Table 2](#T2){ref-type="table"}\] indicate that actual skin transfer values from hard and soft surfaces would be less than the default values necessarily employed in the present estimation. As a consequence, the SRCL estimates presented in [Tables 11](#T11){ref-type="table"} and [12](#T12){ref-type="table"} for HD are considered highly protective.

This analysis indicates that the most protective approach for all examined exposure durations and populations would be to select the compound-specific 24-h SRCL estimates for the transit passenger child receptor for application as compound-specific screening criteria for persistent CWAs.

SRCL Results for Degradation Products of HD and VX {#s34}
--------------------------------------------------

Compound-specific parameters and toxicity values were applied in a similar manner to estimate SRCL values for degradation products of HD and VX. Results are summarized in [Table 13](#T13){ref-type="table"} for the child transit passenger, which represents the most susceptible subpopulation evaluated in the surface contact assessment.

This analysis indicates that the most protective approach for all examined exposure durations and populations would be to select the compound-specific 24-h SRCL estimates for the transit passenger child receptor for application as compound-specific screening criteria for these key degradation products of persistent CWAs.

Exposure Time Fraction and Route-Specific Relative Contribution {#s35}
---------------------------------------------------------------

The World Trade Center (WTC) Indoor Assessment ([@R25]) model incorporates an exposure time fraction for the dermal exposure route, and those portions of the WTC model were followed for the current analysis. The WTC model mathematically assumes that, once contact with a contaminated surface is terminated, exposure also terminates. Other USEPA models of dermal exposure assume that a contaminant resides in a medium such as soil, with adherence of the medium to the skin throughout the day with continuing exposure even when the receptor is not at the original exposure site. [@R116] currently does not address more refined approaches for indoor surfaces \[(as used in the WTC report of [@R25] and the present analysis\]. The airport scenario considers direct contact with a surface residue and does not assume the presence of a delivery medium.

###### 

Estimated HD and VX Degradation Product Surface Removal Contaminant Levels (SRCLs) for child transit passengers.[^a^](#T13FN1){ref-type="table-fn"}

  CWA Degradation Product              Transit Passenger SRCL~4~[^b^](#T13FN2){ref-type="table-fn"}[^c^](#T13FN3){ref-type="table-fn"} Protective estimate (mg/cm^2^ surface, continuous exposure)   Transit Passenger SRCL~24~[^b^](#T13FN2){ref-type="table-fn"}[^d^](#T13FN4){ref-type="table-fn"} Protective estimate (mg/cm^2^ surface, continuous exposure)
  ------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------
  TDG (thiodiglycol)                   1.06 × 10^2^                                                                                                                                                  1.77 × 10^1^
  EMPA (ethyl methylphosphonic acid)   7.08                                                                                                                                                          1.18
  MPA (methyl phosphonic acid)         5.06                                                                                                                                                          8.44 × 10^−1^
  EA2192                               1.89 × 10^−3^                                                                                                                                                 3.15 × 10^−4^

^a^Chemical formulae: TDG, C~4~H~10~O~2~S; EMPA, C~3~H~9~O~3~P; MPA, CH~5~O~3~P; EA2192, C~9~H~22~NO~2~PS.

^b^The "child passenger" estimate employs child-specific information regarding object mouthing behavior and dermal contact with surfaces, and is thus a protective estimate for adult transit passengers. Passenger SRCL estimates incorporate contaminant transfer from hard and soft surfaces to the eye, skin, and mouth (incidental ingestion), as well as potential particle inhalation due to resuspension from surfaces.

^c^SRCL4 assumes average exposure dwell time of 4 continuous h (incorporates inhalation toxicity value for exposure durations ≤8 h).

^d^SRCL~24~ assumes maximal exposure dwell time of 24 continuous h (incorporates inhalation toxicity value for exposure durations \>8 h but ≤24 h).

The relative contribution of each exposure route *(e.g.*, ingestion, ocular, dermal skin, and resuspension inhalation) to the total SRCL has been characterized by calculating each route-specific component of the SRCL equation. The estimated route-specific relative contributions for transit passengers and various airport employees and personnel potentially exposed to HD or VX are summarized in [Tables 14](#T14){ref-type="table"} and [15](#T15){ref-type="table"}. The relative contribution for HD and VX degradation products for the child transit passenger population is summarized in [Table 16](#T16){ref-type="table"}. For verification purposes, the present analysis incorporates a stochastic model approach employed by CalEPA ([@R100; @R101; @R102]).

For child transit passengers, the largest estimated component of the composite transit passenger average and maximum VX (and HD) SRCL is that provided by indirect (incidental, nondietary) ingestion (approximately 80%) due to object mouthing behavior. Direct eye exposure accounts for 15 to 16%, with the bulk of the remainder provided by direct dermal. The contribution of resuspension inhalation is much less than 1% for this population.

For VX, the largest estimated component of the composite airport personnel and employee average and maximum VX SRCL is that provided by indirect (incidental, nondietary) ingestion (57%), whereas direct eye exposure accounts for 35%; the remainder is comprised of direct dermal (skin) exposure (6.6%) and resuspension inhalation (approximately 1%). Estimates for HD are similar to those of VX for reasons outlined above.

###### 

Estimated contribution of each exposure route to Sulfur Mustard and Agent VX SRCLs for child transit passengers.[^a^](#T14FN1){ref-type="table-fn"}

  CWA                   Transit passenger 4-h dwell time (%)   Transit passenger 24-h dwell time (%)
  --------------------- -------------------------------------- ---------------------------------------
  Sulfur mustard (HD)   Ingestion: 79.1                        Ingestion: 79.1
                        Eye: 15.5                              Eye: 15.5
                        Dermal skin: 5.4                       Dermal skin: 5.4
                        Resuspension inhalation: \<1           Resuspension inhalation: \<1
  VX                    Ingestion: 81.7                        Ingestion: 81.8
                        Eye: 16.0                              Eye: 16.0
                        Dermal skin: 2.2                       Dermal skin: 2.2
                        Resuspension inhalation: 0.14          Resuspension inhalation: 0.07

^a^Chemical formulae: HD, C~4~H~8~Cl~2~S; VX, C~11~H~26~NdO~2~PS.

In general, estimated relative contributions for HD and VX degradation products mirror those for the parent compound, except for EA 2192, which is not absorbed through the skin and is not an inhalation hazard ([@R67]). The resuspension inhalation component for EA 2192 is minimal.

SRCL Evaluation {#s36}
---------------

Although the logic and assumptions of [@R25] were largely employed in the present analysis, a number of refinements were added to more closely simulate conditions expected in a transportation hub that has been the target of a deliberate CWA or TIC release. These refinements include:

###### 

Estimated contribution of each exposure route to Sulfur Mustard and Agent VX SRCLs for adult airport employees and personnel.[^a^](#T15FN1){ref-type="table-fn"}

  CWA                   Airport employee/personnel 8-h workshift (%)   Airport employee/personnel 12-h workshift (%)
  --------------------- ---------------------------------------------- -----------------------------------------------
  Sulfur mustard (HD)   Ingestion: 52.2                                Ingestion: 52.3
                        Eye: 32.3                                      Eye: 32.3
                        Dermal skin: 15.5                              Dermal skin: 15.4
                        Resuspension inhalation: \<1                   Resuspension inhalation: \<1
  VX                    Ingestion: 57.2                                Ingestion: 56.9
                        Eye: 35.4                                      Eye: 35.1
                        Dermal skin: 6.6                               Dermal skin: 6.6
                        Resuspension inhalation: 0.74                  Resuspension inhalation: 1.4

^a^Chemical formulae: HD, C~4~H~8~Cl~2~S; VX, C~11~H~26~NO~2~PS.

###### 

Estimated contribution of each exposure route to Degradation Product SRCLs (mg/cm^2^ of surface) for child transit passengers.[^a^](#T16FN1){ref-type="table-fn"}

  CWA Degradation Product   Transit Passenger, 4-h dwell time (%)                            Transit Passenger, 24-h dwell time (%)
  ------------------------- ---------------------------------------------------------------- ----------------------------------------------------------------
  TDG (thiodiglycol)        Ingestion: 83.0                                                  Ingestion: 83.1
                            Eye: 16.2                                                        Eye: 16.2
                            Dermal skin: 0.6                                                 Dermal skin: 0.6
                            Resuspension inhalation: \<1                                     Resuspension inhalation: \<1
  EMPA (ethyl               Ingestion: 79.0                                                  Ingestion: 79.1
    methylphosphonic        Eye: 15.4                                                        Eye: 15.4
    acid)                   Dermal skin: 5.43                                                Dermal skin: 5.44
                            Resuspension inhalation: \<1                                     Resuspension inhalation: \<1
  MPA (methyl               Ingestion: 79.0                                                  Ingestion: 79.1
    phosphonic acid)        Eye: 15.4                                                        Eye: 15.4
                            Dermal skin: 5.43                                                Dermal skin: 5.44
                            Resuspension inhalation: \<1                                     Resuspension inhalation: \<1
  EA2192                    Ingestion: 83.7                                                  Ingestion: 83.7
                            Eye: 16.3                                                        Eye: 16.3
                            Dermal skin: NA[^b^](#T16FN2){ref-type="table-fn"}               Dermal skin: NA[^b^](#T16FN2){ref-type="table-fn"}
                            Resuspension inhalation: NA[^b^](#T16FN2){ref-type="table-fn"}   Resuspension inhalation: NA[^b^](#T16FN2){ref-type="table-fn"}

^a^Chemical formulae: TDG, C~4~H~10~O~2~S; EMPA, C~3~H~9~O~3~P; MPA, CH~5~O~3~P; EA2192, C9H22NO2PS.

^b^EA 2192 is a solid, is not an inhalation hazard, and is not absorbed through the skin in aqueous or alcohol solutions ([@R67]).

-   Exposure duration (ED) and exposure frequency (EF) have been developed for transit passengers and airport personnel/employees based on agent degradation analysis from [@R135], *this issue)* characterizing surfaces in the post-decontamination environment. This method more accurately reflects the expected, acute nature of potential post-decontamination exposures from residual CWAs or TICs in the specific airport-release scenario under consideration *(e.g.*, one-time only release with passenger and airport personnel re-entry only after release device is removed and/or neutralized, decontamination is complete, and monitoring has characterized atmospheres and surfaces as suitable for re-occupancy). Traditional exposure assessments are based on human activity patterns and not the likely presence of contamination ([@R111]). However, there is precedence to include dissipation terms in risk calculations for dust on surfaces, as in the WTC assessment ([@R25]), and evaluations of radioactive decay. In the case of the present analysis, ED and EF are based on the rapid and well-characterized degradation reactions taking place during the decontamination phase ([@R135], *this issue;* [@R142]; [@R141]; [@R105; @R106]; others). Hence, the SRCL equations do not include a decay rate variable.

-   Addition of hand-to-eye exposure estimates because the eye is considered the most susceptible target organ for sulfur mustard or nerve agent exposures.

-   Addition of a resuspension factor for dust inhalation arising from foot traffic or cleaning activities.

-   Development of compound-specific, subchronic oral RfD estimates (7 × 10^−5^ mg HD/kg/day; 2 × 10^−6^ mg VX/kg/day) by deletion of the subchronic-to-chronic uncertainty factor previously incorporated into chronic RfD estimation ([@R92].

-   Use of inhalation toxicity values equivalent to estimated airborne re-entry screening guidelines ([Table 2](#T2){ref-type="table"}).

In addition, information characterizing transit passenger dwell time in airport terminals and based on recent traveler interviews conducted at LAX, was incorporated into the transit passenger estimates ([Table 11](#T11){ref-type="table"}). The airport employee and personnel estimates incorporate standard work shifts of 8 and 12 h ([Table 12](#T12){ref-type="table"}).

This evaluation considers that the most protective estimation for screening surfaces prior to re-entry by the public (including various airport employees and personnel) is to apply SRCL estimations developed for the toddler child transit passenger. This recommendation is based on the fact that a toddler represents the population group for which hand-to-mouth and body-skin exposure is maximized because of frequent object mouthing activities and skin contact with surfaces. Furthermore, because the most reliable values for the FTSHS parameter (fraction transferred from surface to hand skin) (and by extension, the FTSBS body skin parameter) is available for VX, the SRCL estimates for VX are more reliable than those for HD, and are thus preferable. Additional protection is provided by selecting the smallest SRCL estimate for VX-that estimated for 24-h continuous exposure duration ([Table 11](#T11){ref-type="table"}).

Surface Removal Contaminant Levels (SRCLs) can be calculated or modified quickly following the equations presented in this analysis and use of spreadsheets or hand calculations. This simplicity offers great utility in the event of a terrorist attack. However, to test the validity of the deterministic approach, comparison to a model requiring greater computing power was desired. For verification purposes, a stochastic model approach employed by CalEPA ([@R100; @R101; @R102]) was compared to the present analysis. The Stochastic Human Exposure and Dose Simulation Model for Multimedia, Multipathway Chemicals (SHEDS; ver 3) was used by CalEPA to assess children\'s exposure to methamphetamine residues on surfaces ([@R104]; [@R146]); version 3 has been the most current edition available for investigative use at the time of the present analysis.

The SHEDS probabilistic model was developed by the USEPA National Exposure Research Laboratory and estimates a total absorbed dose (mg/kg-day) for a known surface concentration by incorporating inputs from non-dietary ingestion (hand-to-mouth, object-to-mouth), inhalation and dermal contact time-series exposures for specified cohorts. For the present analysis, the California methamphetamine estimates ([@R100; @R101; @R102]) were repeated using the SHEDS model. Once the model had been verified, the present analysis evaluated LAX-specific exposure parameters (see [Tables 9](#T9){ref-type="table"} and [10](#T10){ref-type="table"}, and accompanying text) as well as compound-specific chemical and physical parameters. For nerve agent VX, the SHEDS model estimated a surface concentration guideline of 0.1 ug VX/cm^2^ for the child transit passenger and 24-h contact exposure duration; this result was within a factor of 3 of the guideline value for the same receptor and contact exposure duration (0.3 ug VX/cm^2^, [Table 11](#T11){ref-type="table"}) estimated by means of the deterministic SRCL approach used in this present analysis. Note that the SRCL approach represents an expansion from SHEDs in that SRCL also considers input from ocular (hand-to-eye) exposure. The authors believe that the deterministic approach to calculating SRCLs compares favorably with results obtained from application of the SHEDS probabilistic model.

According to the SHEDS website (<http://www.epa.gov/heasd/products/sheds_multimedia/sheds_mm.html>), development of SHEDS-Multimedia version 4 is ongoing at this writing (August 2010); when ready, Version 4 will allow for cumulative (multi-chemical) or aggregate (single chemical) assessments and combine residential and dietary modules. A USEPA Science Advisory Panel (SAP) review of SHEDS-Multimedia version 4 occurred in July 2010; at present, the Version 4 model release date has not been announced.

An evaluation of the protective nature of the VX SRCL can be performed by comparisons with published estimates of VX dermal toxicity (human LD~50~ of 4 μg VX/cm^2^ when applied as undiluted agent directly to skin and without considering transfer losses that occur during skin contact with surfaces; [@R137]) and calculation of the amount of VX potentially transferred to the skin after contact with a surface contaminated by the 24-h toddler transit passenger SRCL of 3.08 × 10^−4^mg VX/cm^2^ (0.3 μg VX/cm^2^). Application of the estimated FTSBS for VX (0.0009 for vinyl and 0.0076 for carpet; [Table 9](#T9){ref-type="table"}) results in an estimated VX transfer to body skin of between 2.8 × 10^−4^ μg VX/cm^2^ to 2.3 × 10^−3^ μg VX/cm^2^. This range represents a difference of approximately 10^3^ to 10^4^ less than the published human dermal LD~50~ of 4 μg VX/cm^2^ for VX ([@R137]). It is noted that estimates of transfer to the skin of the hand are incorporated into the above FTSBS consideration.

These ratios are protective when compared with other toxicological information for VX, such as the difference between rat threshold lethality (1-h threshold lethality in female rats is 0.50 mg VX/m^3^, or 500 μg VX/cm^3^) and reversible EC~50~ for miosis (considered a nonadverse effect) (1-h miosis EC~50~ in female SD rats is 0.002 mg VX/m^3^, or 2 μg VX/cm^3^; [@R14; @R15; @R16; @R17]). The difference between no-adverse effect (EC~50~ miosis) and threshold lethality in SD rats is a factor of 10^2^; thus, the greater difference of 10^3^ to 10^4^ exhibited by the difference between the toddler transit passenger SRCL and estimated human dermal LD~50~ is an indication of the protective nature of the SRCL estimate for VX. Although the [@R14; @R15; @R16; @R17] data are for VX vapor exposure, relative ratios between lethality and no adverse effect are considered comparable given the same mechanism of toxicity; for example, anticholinesterase activity, is the source of toxic response in both cases.

CONCLUSIONS {#s37}
===========

If a chemical terrorist incident should occur tomorrow, it is important to have an immediate set of appropriate and reasonable clearance goals from which to begin recovery. Exposure guidance and screening levels for use in chemical terrorist remediation decision-making have been developed in a national case study sponsored by the Department of Homeland Security in partnership with the Bradley International Terminal (TBIT) at the Los Angeles International Airport (LAX; Los Angeles, CA). Part II of the assessment (presented here) documents development of human-health based multipathway decision criteria. Exposure routes evaluated include direct ocular vapor and vapor inhalation, percutaneous vapor, surface contact, hand-to-eye, hand-to-mouth, non-dietary and dietary ingestion and resuspension inhalation ([Figure 3](#F3){ref-type="fig"} and [Tables 1](#T1){ref-type="table"}-[16](#T16){ref-type="table"}). The scenario compounds under consideration are the chemical warfare agent (CWA) nerve agents tabun (GA), sarin (GB), soman (GD), cyclosarin (GF), and VX as well as the vesicant agent sulfur mustard (HD); and the toxic industrial compounds (TIC) phosgene (CG), hydrogen cyanide (AC), and cyanogen chloride (CK). Exposure guidelines for CW agent degradation products of interest are also developed and provided.

This article presents first-time, open-literature documentation of multi-pathway and health-based remediation exposure guidelines for all nine of these chemical terrorist threat compounds and their degradation products. These guidelines are suitable for application to various civilian populations, and are both health-protective and reasonable for use as clearance decision criteria during remediation of a chemical terrorist event within a major domestic transportation hub. Personal protective equipment guidelines for decontamination personnel are also identified.

Emphasis is placed on compound-specific exposure guidelines that already exist, are published and accessible to the public, have undergone credible peer and public review, are health-based and protective, and have demonstrated utility in use and practice. Selection of compound-specific critical effects used as point(s) of departure for this analysis focuses on reversible, non-adverse (often local) effects that exhibit well-defined dose response, such as EC~50~ for miosis in a susceptible gender following nerve agent vapor exposure. With application of uncertainty factors, the resulting exposure guidance concentrations are protective for all segments of the general population, including susceptible subpopulations. When published low-level exposure guidelines were not available or suitable (e.g., for phosgene, hydrogen cyanide, cyanogen chloride) application of standard risk assessment methods resulted in appropriate guidance values.

Because of their recognized scientific credibility and expanding uses in domestic preparedness planning by affected communities as well as Federal and state authorities, the Acute Exposure Guideline Level (AEGL) concentrations published by the Committee on Toxicology of the National Research Council are considered by this analysis as protective, appropriate and useful for making site-access re-entry determinations for the traveling public, airport personnel, and vendors. This analysis further considers application of the mildest effect tier (AEGL-1) to be appropriate, and application of the 8-h AEGL-1 concentrations (the lowest values) as reasonable criteria for all transit passenger stay times ≤8 h as well as for airport personnel and vendors ([Table 2](#T2){ref-type="table"}). Selecting the minimal exposure concentrations developed for assumed 8-h exposure durations is a highly protective assumption for LAX transit passengers given the one-time only release scenario and the fact that most passengers spend ≤4 h in the most heavily used LAX terminals. It is acknowledged that use of any given dwell ("stay") time assumption may be airport-specific; nevertheless, the 8-h continuous-exposure duration is considered protective for post-decontamination applications. To address those rare situations where public dwell times may be \>8 h but \<24 h, alternative clearance goals are derived from standard time-extrapolation protocols, and provide additional flexibility to decision-makers. The vapor exposure guidance range provided in [Table 2](#T2){ref-type="table"} represents both reasonable maximum and alternative re-entry screening guidelines.

Given previous minimal guidance for surface contact exposures to the airport threat compounds, this analysis develops a novel and deterministic approach to estimate non-adverse surface residue concentrations for the persistent nerve agent VX, the persistent vesicant agent HD and degradation products of concern. Unlike other surface assessments, this analysis considers hand-to-eye exposure estimates as well as a resuspension factor for dust inhalation arising from foot traffic or cleaning activities. Population exposure assessment determined that toddlers are the most susceptible subpopulation for surface contact exposure due to object-mouthing and other age-specific behaviors favoring transfer from surfaces; the resulting Surface Removal Contaminant Levels (SRCLs; in mg/cm^2^ for CWAs) (see [Tables 11](#T11){ref-type="table"}-[13](#T13){ref-type="table"}) are thus protective for adults. Results compare well with those of the SHEDS probability model developed by the USEPA National Exposure Research Laboratory for contaminated surfaces, and are consistent with logic employed by CalEPA in assessing children\'s exposure to methamphetamine residues on surfaces of buildings used as clandestine production facilities. Compound-specific SRCLs can be calculated or modified quickly following application of the equations ([Figures 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}) and input parameters ([Tables 9](#T9){ref-type="table"}-[10](#T10){ref-type="table"}) presented in this analysis, with use of spreadsheets or hand calculations. This simplicity offers great utility in the event of a terrorist attack.

Some assumptions required to characterize SRCL exposure parameters would be improved by means of compound-specific testing; the most significant are those characterizing the fraction transferred from surface to skin of the hand (FTSHS) or body (FTSBS). Since the authors could locate no HD-specific skin transfer data from "hard" or "soft" surfaces, FTSHS and FTSBS values utilized for sulfur mustard are necessarily standard USEPA defaults for hard and soft surfaces. Examination of the chemical and physical properties of HD indicates that such default transfer values are over-estimates.

It is acknowledged that relevant work is ongoing in many fields that will continue to inform future evolution of clearance guidelines. Nevertheless, [Tables 17](#T17){ref-type="table"}-[19](#T19){ref-type="table"} summarize protective clearance goals for the nine threat compounds and their principal degradation products as developed during the current analyses and recommended for application to the airport remediation scenario. These tables are intended to serve as an aid to decision-makers for pre-planning, and for actual use should a similar incident occur in the future. By providing rationale for reasonable and scientifically supported procedures and health-based criteria, this analysis provides decision-makers with an efficient and effective approach as well as flexibility by which to weigh numerous judgments (decontamination personnel safety, public health, time, funds, resources, public perception, and other concerns) required to establish clearance guidelines for remediating airport facilities in which hazardous chemical release has occurred.

This study\'s findings are not only crucial to the development of preplanning goals for remediation and release of airport terminals in the event of chemical terrorist attack, but are also applicable to other transportation hubs such as bus, train, ferry, and metro terminals.

###### 

Recommended clearance exposure guidelines for transit passengers as well as various airport employees and personnel for selected CWAs and TICs in air and on surfaces (airborne for inhalation/ocular exposure; percutaneous vapor for protective clothing breach with full respiratory protection; and surface residual for "toddler" transit passenger SRCLs). For use during clearance decision-making following chemical terrorist release of selected CWA or TIC compounds under the LAX remediation protocol.

                                   Reasonable Maximum Re-entry Screening Guidelines (mg/m^3^)   Alternative Re-entry Screening Guidelines (mg/m^3^)   CWA Personnel Escape Guidelines (mg/m^3^) for 30-min percutaneous exposure   Transit Passenger SRCL~4hr~ (mg/cm^2^ surface, calculated; 4 h continuous exposure duration)   Transit Passenger SRCL~24hr~ (mg/cm^2^ surface, calculated; 24 h continuous exposure duration)
  -------------------------------- ------------------------------------------------------------ ----------------------------------------------------- ---------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------
  Tabun (GA)                       \< 0.0010                                                    \< 0.0003                                             11.1                                                                         c                                                                                              c
  Sarin (GB)                       \< 0.0010                                                    \< 0.0003                                             6.0                                                                          c                                                                                              c
  Soman (GD) and Cyclosarin (GF)   \< 0.00050                                                   \< 0.0002                                             1.5                                                                          c                                                                                              c
  VX                               \< 0.000071                                                  \< 0.000024                                           0.13                                                                         \<1.85 × 10^−3^                                                                                \<3.08 × 10^−4^
  Sulfur mustard (H/HD)            \< 0.008                                                     \< 0.003                                              0.1                                                                          \<1.77 × 10^−3^                                                                                \<2.95 × 10^−4^
  Hydrogen cyanide (AC)            \< 1.1                                                       \<0.37                                                d                                                                            c                                                                                              C
  Cyanogen chloride (CK)           \<0.25                                                       \<0.08                                                d                                                                            c                                                                                              c
  Phosgene (CG)                    \<0.08                                                       \<0.03                                                d                                                                            c                                                                                              c

^a^Equivalent to the 8-h AEGL-1 for nerve agents and sulfur mustard ([@R86]), and hydrogen cyanide ([@R85]). Derivation of screening guidelines for phosgene and cyanogen chloride is described in this article.

^b^Derived by applying standard protocols and straight-line extrapolation from the 8-h AEGL-1 concentration ([@R84]). The same protocols were used to derive the alternative re-entry screening guidelines for phosgene and cyanogen chloride.

^c^Because of the volatility of G-series nerve agents, HCN, phosgene, and cyanogen chloride, these volatile compounds are not considered persistent; there are thus insufficient data from which to estimate surface residues. If there is interest in surface sampling for these volatile compounds, the SRCL concentrations estimated for nerve agent VX can be employed. Doing so is a protective approach given the SRCL assumptions of VX persistence and toxicity, as well as the assumed frequency of child object mouthing behavior and dermal contact with surfaces.

^d^Not determined by NIOSH.

###### 

Recommended clearance exposure guidelines for incidental soil and drinking water ingestion of selected CWAs and TICs.[^a^](#T18FN1){ref-type="table-fn"}

                      Residential soil (lifetime)   Industrial soil (lifetime)   15 liter/day consumption (\<7 day)                 
  ------------------- ----------------------------- ---------------------------- ------------------------------------ ------------- -------------------------------------
  Tabun (GA)          \<2.8 (est.)                  \<3.1                        \<68 (est.)                          \<82          \<46
  Sarin (GB)          \<1.3 (est.)                  \<1.6                        \<32 (est.)                          \<41          \<9.3
  Soman (GD) and      \<0.22 (est.)                 \<0.31                       \<5.2 (est.)                         \<8.2         \<4 (GD only; also
    Cyclosarin (GF)                                                                                                                 applicable for generic nerve agent)
  VX                  \<0.042 (est.)                \<0.047                      \<1.1 (est.)                         \<1.2         \<5
  Sulfur mustard      \<0.01 (est.)                 \<0.55                       \<0.3 (est.)                         \<14          \<47
    (H/HD)                                                                                                                          
  Hydrogen cyanide    \<1.6 × 10^3^                 Unavailable                  \<2.0 × 10^4^                        Unavailable   \<2
    (AC)                                                                                                                            
  Cyanogen chloride   \<3.9 × 10^3^                 Unavailable                  \<5.1 × 10^4^                        Unavailable   Unavailable
    (CK)                                                                                                                            
  Phosgene (CG)       Unavailable                   Unavailable                  Unavailable                          Unavailable   Unavailable

^a^Calculated Regional Screening Levels (RSLs) for residential soil (See [Table 6](#T6){ref-type="table"} and footnote d) are duplicative of above PRG and RBC estimates for residential soil.

###### 

Summary of clearance exposure guidelines for principal CWA degradation products on surfaces ("toddler" transit passenger SRCL), and via incidental soil ingestion (both residential and industrial).[^a^](#T19FN1){ref-type="table-fn"}

                                                                      Residential soil   Industrial soil                  
  ------------------------------------ -------------- --------------- ------------------ ----------------- -------------- -----
  TDG (thiodiglycol)                   1.06 × 10^2^   1.77 × 10^1^    2.4 × 10^4^        6.0 × 10^4^       8.2 × 10^5^    
  EMPA (ethyl methylphosphonic acid)   7.08           1.18            1.7 × 10^3^        4.2 × 10^3^       5.7 × 10^4^    
  MPA (methyl phosphonic acid)         5.06           8.44 × 10^−1^   1.2 × 10^3^        3.0 × 10^3^       4.1 × 10^4^    
  EA2192                                              1.89 × 10^−3^   3.15 × 10^−4^      4.7 × 10^−2^      6.8 × 10^−1^   1.2

^a^Regional Screening Level (RSL) user guide disclaimer states that the RSL guidance is not mandatory, does not provide binding rules, and points out that alternative approaches for risk assessment may be more appropriate on a site-specific basis ([@R120], see <http://www.epa.gov/reg3hwmd/risk/human/rb-concentration_table/usersguide.htm>). Use of the RSLs has been accepted only by Regions 3, 6, and 9; other EPA regions have not officially approved the application of RSLs. Thus, Preliminary Remediation Goals (PRGs) other than RSLs are still in use within the remaining seven EPA Regions, and reference to PRG use is valid. Also [Table 6](#T6){ref-type="table"}.
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TDG

:   thiodiglycol

THQ

:   toxic hazard quotient

TIC

:   toxic industrial compounds

UF~A~

:   interspecies uncertainty factor

UF~H~

:   intraspecies uncertainty factor

USACHPPM

:   U.S. Army Center for Health Promotion and Preventive Medicine

USEPA

:   U.S. Environmental Protection Agency

VX

:   nerve agent; NATO code

WTC

:   World Trade Center

WWI

:   World War I
